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ABSTRACT 
 
Tissue Engineering has been widely studied as an alternative approach to treat 
tissue defects resulting from a disease or injury. Most of these studies use materials 
developed into different forms/structures as templates for cell attachment (or 
entrapment) and proliferation. 
The present thesis, focused on the development and characterization of distinct 
natural origin polymeric systems that can find different applications in tissue 
engineering. 
The first system studied consists of membranes and 3D-scaffolds based on 
chitosan, a biodegradable polymer of natural origin that shows adequate properties 
for several potential biomedical applications such as wound healing, skin substitutes, 
drug delivery, cell encapsulation and others. In this work, it was evaluated the general 
cytotoxicity and biocompatibility of several different chitosan membranes and 3D-
chitosan scaffolds formulations, but the major focus was on the assessment of the 
effect of plasma surface treatments on the ability of chitosan membranes to promote 
cell adhesion and proliferation. For this purpose, the surface of the chitosan based 
membranes was modified by plasma treatment, using argon and nitrogen gas. 
Different in vitro cell culturing assays performed (MEM, MTT, MTS) showed that such 
treatments were useful to obtain enhanced cell attachment and proliferation on 
chitosan membranes. In fact, chitosan membranes treated by plasma, demonstrated a 
high potential for biomedical applications, such as substrates for skin tissue 
engineering. Additionally, plasma treatment procedure seems to have potential to be 
implemented in other chitosan-based materials, such as scaffolds for tissue 
engineering. 
The second part of the work developed under this thesis was focused on the 
development of a novel cell encapsulation system based on two different natural 
origin polymers, namely alginate, a well know polymer widely studied for cell 
encapsulation, drug delivery, and carrageenan, a natural origin polymer that has not 
been significantly studied for biomedical applications despite its intrinsic interesting 
properties. Cell encapsulation systems allow to obtain constructs with a homogenous 
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cell distribution that can adapt to the shape of the tissue defect to be treated, as the 
microcapsules containing the cells can be easily injected into a tissue defect, using 
non-invasive surgical procedures. 
Microcapsules were developed using kappa and iota-carrageenan, as well as a 
mixture of sodium alginate and iota-carrageenan. In all cases, chitosan was used to 
form the membrane of the capsules. All the developed capsules exhibited spherical 
shape, smooth surface and revealed good stability in PBS and in culture medium. The 
obtained results demonstrate that the incorporation of iota-carrageenan improves the 
stability of alginate based capsules and suggest that these capsules show adequate 
permeability for cell encapsulation without the need for additional citrate treatments 
(as it happens for alginate capsules). In fact, cell encapsulation experiments, using 
sodium alginate and iota-carrageenan (30/70%) capsules demonstrated that is possible 
to maintain cellular viability, demonstrating the potential of the developed system for 
tissue engineering applications. 
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RESUMO 
 
A engenharia de tecidos tem sido estudada extensamente como uma alternativa 
para o tratamento de tecidos danificados por uma doença ou trauma. A maioria destes 
estudos utiliza materiais desenvolvidos para o efeito com formas/estruturas 
diferentes, como suportes para a proliferação e adesão de células (ou encapsulamento 
de células em sistemas poliméricos). 
O trabalho apresentado, focou-se no desenvolvimento e caracterização de 
sistemas poliméricos de origem natural distintas com aplicações diferentes em 
engenharia de tecidos. 
Na primeira parte do trabalho estudou-se à biocompatibilidade de membranas e 
estruturas porosas (“3D-scaffolds”) baseadas no quitosano, um polímero 
biodegradável de origem natural, que exibe propriedades adequadas para diversas 
potenciais aplicações biomédicas, relacionadas com a cicatrização de feridas, suportes 
para engenharia de tecidos, libertação controlada de fármacos e encapsulamento de 
células, entre outras. Foi avaliada a citotoxicidade e a biocompatibilidade de 
membranas com diferentes formulações e estruturas tridimensionais porosas 
baseadas no quitosano, sendo o objectivo principal a avaliação do efeito do 
tratamento de plasma na superfície das membranas de quitosano na promoção a 
adesão e proliferação de células. A superfície das membranas de quitosano foi 
modificada utilizando um tratamento por plasma, usando árgon e azoto. Foram 
realizados diferentes testes de culturas celulares in vitro (MEM, MTT, MTS), os quais 
demonstraram que os tratamentos por plasma, melhoram significativamnte á adesão e 
proliferação de células nas membranas de quitosano. De facto, as membranas de 
quitosano tratadas por plasma demonstraram um elevado potencial para aplicações 
em engenharia de tecidos. 
A segunda parte do trabalho consistiu no desenvolvimento de um novo sistema 
para encapsulamento de células baseado em dois polímeros diferentes, ambos de 
origem natural, nomeadamente o alginato, um conhecido polímero extensamente 
estudado para encapsulamento de células e em sistemas para a libertação de 
fármacos, e o carragenano que, apesar exibir algumas propriedades intrínsecas 
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interessantes, não tem sido muito estudado para aplicações biomédicas. Os sistemas 
de encapsulamento de células permitem obter sistemas híbridos tridimensionais de 
células e materiais (constructs) com uma distribuição celular homogénea que podem 
adaptar-se à forma do defeito do tecido a ser tratado, uma vez que as microcápsulas 
podem ser facilmente injectadas no defeito a tratar, utilizando técnicas cirurgicas de 
invasão mínia. Estes sistemas híbridos podem ser usados para a regeneração de 
diversos defeitos tecidulares e podem também ser usados simultaneamente como 
veículos para a libertação de agentes bioactivos.  
As microcápsulas foram desenvolvidas usando kappa-carragenano e o iota-
carragenano assim como misturas de alginato de sódio e de iota-carragenano. Em 
todos os casos foi utilizado o quitosano para formar a membrana envolvente das 
cápsulas. Todas as cápsulas desenvolvidas exibem uma forma esférica, uma superfície 
lisa e estabilidade adequada em PBS e no meio de cultura. Os resultados obtidos 
demonstraram que a incorporação do iota-carragenano melhora a estabilidade das 
cápsulas baseadas em alginato, o que indica que estas cápsulas apresentam 
permeabilidade adequada para o encapsulamento de células sem a necessidade de um 
tratamento adicional de citrato (como acontece para as cápsulas de alginato). Assim 
sendo, os ensaios de encapsulamento de células em cápsulas feitas de alginato de 
sódio e iota-carragenano (30/70%) provaram que é possível manter a viabilidade 
celular, demonstrando o potencial do sistema desenvolvido para aplicações em 
engenharia de tecidos. 
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CHAPTER 1 
1 INTRODUCTION 
 
1.1 POLYMERS FOR BIOMEDICAL APPLICATIONS 
In the past years, the field of Tissue Engineering has opened a new and exciting 
range of applications for biodegradable polymers. 
Tissue Engineering is an emerging interdisciplinary field and one of the major 
components of regenerative medicine which follows the principles of cell 
transplantation, materials science, and engineering towards the development of 
biological substitutes that can restore and maintain normal tissue function [1]. 
Biomaterials, in general, provide a space (2D or 3D) for the cells to form into new 
tissue with appropriate structure and function. Moreover, the biomaterials may allow 
for the delivery of cells and appropriate bioactive factors, to the desired site in the 
body [1, 2]. As the majority of mammalian cell types are anchorage dependent, and 
will die if no cell adhesion substrate is available, the biomaterials play an important 
role as support structures for tissue regeneration. For this type of applications, the 
ideal biomaterial should be biodegradable and bioresorbable to support the 
replacement of normal tissue without inflammation [1, 2]. Degradation products, if 
produced, should be removed from the body via metabolic pathways at an adequate 
rate in order to keep the concentration of these degradation products in the tissue at a 
tolerable level [1, 3]. 
Although most of the research on Tissue Engineering has focused on polymers that 
have already been studied (and in some cases approved) for other clinical applications, 
the specific and highly demanding requirements for this type of use has encouraged 
the development of new and improved systems, both from natural and synthetic 
origin, as well as combination of natural with synthetic polymers. 
Polymers are a promising class of biomaterials that can be engineered to meet 
specific end-use requirements. They can be selected according to key 'device' 
characteristics such as mechanical resistance, degradability, permeability, solubility 
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and transparency, but most of the currently available polymers need to be improved 
by altering their surface and bulk properties in order to make then suitable for 
biomedical applications. The design of macromolecules must therefore be carefully 
tailored in order to provide the combination of chemical, interfacial, mechanical and 
biological functions necessary for the manufacture of new and improved biomaterials 
(Figure 1-1) [4]. 
 
 
Figure 1-1. Factors to consider when designing a new biomaterial. Biological, medical and engineering 
properties must be integrated to achieve successful biomaterials for tissue regeneration. Adapted from 
[5]. 
 
Polymers have been used widely in medicine and biotechnology [4], in a wide 
range of applications such as surgical devices [6], implants [7], drug delivery systems , 
carriers of immobilized enzymes and cells [8], biosensors, bioadhesives, ocular devices 
[9] and materials for orthopaedic applications [10]. 
Natural origin polymers are abundant and usually biodegradable. Table 1-1, 
presents some of the most important natural and synthetic origin polymers and their 
main biomedical applications. The principal disadvantages of these polymers is related 
to the difficulty in the development of reproducible production methods, because 
their complex structure often renders modification and difficult purification [4]. In the 
case of synthetic polymers, these are available in a wide variety of compositions with 
readily adjusted properties. The main disadvantage of synthetic polymers is the 
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general lack of biocompatibility in the majority of cases, often associated with 
inflammatory reactions [4]. 
The work developed in this thesis has focused on the use of natural origin 
polymers such as chitosan, carrageenan and alginate and therefore, in the next 
sections, these materials will be further described. 
 
Table 1-1. Polymeric biomaterials: main properties and applications. Adapted from [4] 
Polymer Main applications and comments Ref 
NATURAL POLYMERS   
Collagen 
Absorbable sutures, wound dressing sponge, drug 
delivery microspheres. 
[11], 
[12, 13] 
Albumin Cell and drug microencapsulation. [14-18] 
Poly(amino acids): poly(L- lysine), 
poly(L- glutamic). 
Non toxic, non antigenic and biocompatible. Used as 
oligomeric drug carriers. 
[19-21] 
Carboxymethyl cellulose 
Cell immobilization via a combination of ionotropic 
gelation and polyelectrolyte complex formation (e.g. 
with chitosan), drug-delivery systems and dialysis 
membranes. 
[22-24] 
Cellulose sulphate 
Component of polyelectrolyte complex for 
immunoisolation of cells. Complex-forming ability is 
highly sensitive to degree of acetylation.  
[25, 26] 
Agarose 
Largely used as supporting materials in clinical analysis 
and as an immobilization matrix. 
[27, 28]  
Alginate  
Excellent gel-formation properties; its relative 
biocompatible; microstructure and viscosity are 
dependent on the chemical composition (batch to 
batch variations). Used as immobilization matrices for 
cells and enzymes, controlled release of bioactive 
substances, injectable microcapsules for treating 
neurodegenerative and hormone-deficiency disease. 
[6, 29, 
30] 
Carrageenan  
Excellent thermoreversible properties. Used for 
microencapsulation of microorganisms. 
[31-33] 
Hyaluronic acid Excellent lubricant, potential therapeutic agent. [11, 34] 
Heparin and heparin-like 
glycosaminoglycanes 
Antithrombotic and anticoagulant properties. 
Extensively used in surgery. Some are candidates for 
ionotropic gelation and capsule formation. 
[35] 
Dextran and its derivates 
Excellent rheological properties. Plasma expander. 
Widely used as a drug carrier. 
[36, 37] 
Chitosan and its derivates 
Biocompatible, non toxic, excellent gel and film 
forming ability, natural polycation. Widely used in 
controlled delivery systems (e.g. gels, membranes, 
microspheres). 
[38-46] 
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Cont. 
Polymer Main applications and comments Ref 
SYNTHETIC POLYMERS   
Poly (lactic acid), poly (glycolic acid) 
and their copolymers 
Used in sutures, drug delivery systems and in tissue 
engineering. Biodegradable. Often copolymerized to 
regulate degradation time. 
[3, 47, 
48] 
Poly (hydroxyl butyrate), poly 
(caprolactone) and copolymers, 
poly (alkylene succinate), etc. 
Biodegradable, used as a matrix for drug delivery 
systems, cell microencapsulation. Properties can be 
changed by chemical modification, copolymerization 
and blending. 
[49] 
Polyamides (nylons) Sutures, dressing, haemofiltration and blending. [50] 
Polyethylene (low density)  Sutures, catheters, membranes, in surgery. [51, 52] 
Poly (vinyl alcohol) 
Gels and blended membranes are used in drug 
delivery and cell immunoisolation. 
[53] 
Poly (ethylene oxide) 
Highly biocompatible. Different polymer derivatives 
and copolymers have been utilized in a variety of 
biomedical applications. 
[54] 
Poly (hydroxyethyl methacrylate) 
Hydrogels have been used as soft contact lenses, for 
drug delivery, as skin coatings and for 
immunoisolation membranes. 
[9, 55] 
Poly (methyl methacrylate) 
This and its copolymers are used as dental implants 
and in bone replacement. 
[56, 57] 
Poly (tetrafluroethylene) (Teflon®) Vascular grafts, clips and sutures, coating. [58] 
Polydimethylsiloxanes 
A silicone. Implants in plastic surgery, orthopaedics, 
blood bags and pacemakers. 
[59] 
Poly (ortho esters) 
Surface eroding polymers. Application in sustained 
drug delivery, ophthalmology. 
[60-62] 
Polyanhydrides 
Biodegradable, useful in tissue engineering and for the 
release of the bioactive molecules. 
[63, 64] 
 
1.1.1 NATURAL ORIGIN POLYMERS FOR TISSUE ENGINEERING APPLICATIONS 
Naturally derived materials have been used for tissue engineering because they 
offer several advantages related to biological recognition (being similar, often identical 
to macromolecular substances present in the ECM), by the biological environment, 
which is then prepared to recognize and to deal metabolically with these materials [4, 
65].  
 
1.1.1.1 Chitosan 
Chitosan is a linear polysacharide composed of randomly distributed β-(1-4)-
linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit)  
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Figure 1-2), commercially produced by deacetylation of chitin [44, 66]. Chitin is a 
natural polymer found in many arthropods as shells of marine crustaceans (crab, 
shrimp and shellfish), insects and cell walls of fungi. This polysaccharide is the second 
most important compound in nature after cellulose. It is not toxic and is insoluble in 
water, as well in many other solvents such as acetic acid [39, 44, 67-69]. Due to the 
existence of primary amine groups, the structure can be protonated at low pH, and 
chitosan is found to be soluble in moderated acidic solutions. 
 
 
Figure 1-2. Chitosan structure, adapted from [70]. 
 
Chitosan can be formulated into a variety of forms including powders [71], gels 
[40], scaffolds [41, 72, 73], particles [41, 74], microspheres [75], microcapsules [29, 75, 
76] and films [42, 77, 78] with an array of biological properties and applications (Figure 
1-3) [39]. Furthermore, chitosan formulations allow a wide range of molecules to be 
attached. This property allows the delivery of growing factors that could help to 
optimize the physical and biological properties of this material as a matrix scaffold and 
vehicle system in tissue regeneration [39]. 
Chitosan was discovered in 1859, when Rouget boiled chitin in a concentrated 
potassium hydroxide solution, promoting the deacetylation of chitin [79]. Fundamental 
research on chitosan did not start until about a later century [29]. This natural polymer 
can selectively bind substances such as cholesterol, fats, metal ions, proteins and 
tumour cells. Others properties include antifungal effects, antibacterial [80], 
acceleration of wound healing [81, 82], stimulation of the immune system and 
acceleration of plant germination [29].  
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Figure 1-3. Examples of chitosan processing for uses in tissue engineering: Cells may be encapsulated in 
gels or seeded in porous matrices including sponge-like or fibrous structures. Combinations of chitosan 
with other biocompatible materials, such as calcium phosphate or gelatine, are applied to modify 
biomechanical and cell-matrix-interaction properties. Adapted from [68]. 
 
Several research works have shown that membranes formed from this polymer 
could be explored for surgical dressing, guided tissue regeneration and controlled 
release applications [1, 67]. 
Chitosan has been the best researched version of the biopolymer because of its 
ready solubility in dilute acids, rendering the material more accessible for utilization 
and chemical reactions [41]. Chitosan in aqueous acid solutions reacts with anionic 
polysaccharides such as: carboxymethylcellulose [83], xanthan [84, 85], alginate [86, 
87], carrageenan [31, 66], gellan [88], oxychitin and oxypullulan [89-91], chondroitin 
and hyaluronan [92, 93], poly (galacturonic) [94], poly ( -L-glutamic acid) [95] as well 
as synthetic polyanions such as poly (acrylic acid) [96], to give origin to the formation 
of polyelectrolyte complexes [97]. 
The 3B’s Research Group of the University of Minho has ben studying chitosan for 
a wide range of biomedical applications, summarized on Table 1-2, that includes some 
studies based on chitosan and others polymers for tissue engineering applications. 
These materials have been developed into different forms such as membranes [98-
101], 3D-scaffolds [38, 73, 74, 102] and fibres [69] aiming at different tissue 
engineering applications. One of the aims of this work was to assess the biological 
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response of chitosan based membranes and scaffolds developed for biomedical 
applications. 
 
Table 1-2. Some studies developed by the 3B’s Research Group on chitosan based materials. 
Name article Refs. 
Multichannel mould processing of 3D structures from microporous coralline hydroxyapatite 
granules and chitosan support materials for guided tissue regeneration/engineering. 2003. 
[105] 
Starch-chitosan hydrogels prepared by reductive alkylation crosslinking. 2004 [106] 
Production and Characterization of Chitosan Fibers and 3D Fiber Mesh Scaffolds for Tissue 
Engineering Applications. 2004. 
[69] 
Preparation and characterisation in simulated body conditions of glutaraldehyde crosslinked 
chitosan membranes. 2004. 
[99] 
Influence of β-Radiation Sterilization in Properties of New Chitosan/Soybean Protein Isolate 
Membranes for Guided Bone Regeneration. 2004. 
[98] 
Hydroxyapatite Reinforced Chitosan and Polyester Blends for Biomedical Applications. 2005. [38] 
Physical properties and biocompatibility of chitosan/soy blended membranes. 2005. [101] 
Functional nanostructured chitosan/siloxane hybrids. 2005. [107] 
Properties of Melt Processed Chitosan and Aliphatic Polyester Blends. 2005. [108] 
Use of Chemically Modified Chitosan and other natural-origin polymers in tissue engineering 
and drug delivery In Biodegradable Systems in Tissue Engineering and Regenerative 
Medicine. 2005. 
[109] 
Chitosan particles agglomerated scaffolds for cartilage and osteochondral tissue engineering 
approaches with adipose tissue derived stem cells. 2005. 
[74] 
Study of the fosfosal controlled permeation through glutaraldehyde crosslinked chitosan 
membrane. 2006. 
[100] 
Physicochemical Characterization of Novel Chitosan-Soy Protein/TEOS Porous Hybrids for 
Tissue Engineering Applications. 2006. 
[102] 
Enzymatic degradation behaviour of starch conjugated phoshorylated chitosan. 2006. [110] 
 
1.1.1.2 Carrageenan 
Caragenan is a linear heteropolysacharide with ester sulphate groups. It’s main 
chain consists of alternating copolymers of 1,4-  and 1,3-β-D-galactopyranose and 3,6-
anhydro-D-galactopyranose [103, 104] (Figure 1-4). Carrageenan can be found in them 
three major forms that are designated by means of the Greek letters κ (kappa), i (iota) 
and λ (lambda). The main structural difference among them is in the sulphate group 
degree of substitution (Figure 1-5). 
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Figure 1-4. The main carrageenan chain consists of alternating 3-linked-β-D-galactopyranose and 4-
linked- -D-galactopyranose units. Adapted from [115]. 
 
All carrageenans are highly flexible molecules which, at higher concentrations, 
organize into double-helical structures. Gel formation in kappa- and iota-carrageenans 
involves helix formation on cooling from a hot solution together with gel-inducing and 
gel-strengthening; the helix–helix aggregation relies upon specific cation presence 
(Ca2+ and K+), which can screen electrostatic repulsive forces between the participating 
chains by packing within the aggregate structure [31, 111, 112].  
 
Figure 1-5. Chemical structures of kappa, iota and lambda carrageenans. Adapted from [117]. 
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Kappa-carrageenan forms firm and strong rigid gels, while iota-carrageenan 
constitutes soft and elastic gels [31, 113]. Lambda-carrageenan does not gel as the 
high density of charged sulphate encourages an extensive conformation [114]. Table 
1-3 presents some of the basic characteristics of different types of carrageenans. 
 
Table 1-3. Main characteristics of the different forms of carrageenan. Adapted from [114]. 
Chemical 
composition 
Hydrocolloid composed of -D-1.3 and β-D-1.4 galactose residues that are 
sulphated at up to 40% of the total weight. Strong negative charge over normal 
pH range. Associated with ammonium, calcium, magnesium, potassium or 
sodium salts. 
Solubility 
λ is readily soluble in cold or hot aqueous solution. 
K is soluble in hot solution; treatment of aqueous solution with potassium ion 
precipitates. 
Gel formation 
λ does not form gels. 
λ and i form right-handed helices 
Potassium chloride promotes gel formation of k. Calcium ion promotes gel 
formation of i. 
Gel formation in k and i carrageenans involves helix formation on cooling from a 
hot solution together with gel-inducing and gel-strengthening K+ or Ca2+ cations 
respectively  
Metabolism 
Hydrolisis of glycosidic linkages at lower pH, especialy pH ≤3.0; also 
desulphation by sulphatases. 
Source 
Red algae; predominantly aqueous extraction from Chondrus, Gigartina, and 
various Eucheuma species. 
Viscosity 
Near logarithmic increase in viscosity with increasing concentration. Viscosity of 
food-grade carrageenan defined as not less than 5 cps at 75ºC for a 1.5% 
solution; viscosity ranges from 5 to 800 cps for 1.5% solution at 75ºC. 
Molecular weight 
Discrepancies in definitions. Native carrageenan reported to have average 
molecular weight of 1.5x106 – 2x107, food grade carrageenan reported as 
100.000-800.000 or 200.000-400.000. Degraded carrageenan (poligeenan) has 
average molecular weight of 20.000-30.000.  
Properties 
λ and k combine easily with milk proteins to improve solubility and texture, 
serve as thickening agent, emulsifier, stabilizer. 
Major uses 
Milk products, processed meats, dietetic formulations, infant formula, 
toothpaste, cosmetics, skin preparations, pesticides, laxatives. 
Concentration in 
food products 
0.005-2.0% by weight. 
 
Carrageenan has a structural role in the intercellular matrix material of numerous 
species of seaweeds of the class Rhodophyta, where its amorphous structure provides 
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the flexibility required to adapt to the varying stress of tidal and wave motion [103, 
116]. The main substituent is the hemiester sulphate group. These strongly ionic 
groups mutually repel each other to maintain the molecule in a highly extended, 
flexible configuration [103]. 
Carrageenans are widely used in the food and other industries (cosmetic products, 
pesticides and pharmaceutical), as thickening and stabilizing agents. However, its 
predominant role has been in food preparations (a wide variety of food groups), 
because the carrageenans have the ability to substitute fat and to combine easily with 
milk proteins to increase solubility and improve texture [114]. 
Several investigations have associated carrageenan with the induction and 
promotion of intestinal neoplasm and ulceration in numerous animal experiments 
[118-121]. This behaviour is related with gastrointestinal metabolism of carrageenan, 
where food-grade carrageenan may be contaminated with low molecular weight 
carrageenan that may arise during food processing [114]. On the other hand, previous 
studies have demonstrated the benefits of carrageenans in health applications, and 
considered a useful microbicide that inhibits the human immunodeficiency virus (HIV-
1) infection of epithelial at nanomolar concentrations. Moreover, carrageenans have 
also been considered as possible active agent against the cell-associated and cell-free 
virus in genital fluids [122]. The microbicide behaviour, was supported with recent 
studies where it has been demonstrated that carrageenans, as sulphated 
polysaccharides, are potent inhibitors of the infectivity of genital by human papilloma 
virus (HPV) and pseudovirus (PsV) in vitro [113, 123].  
In the present work, carrageenan is proposed as an alternative polymer for the 
development of cell encapsulation systems. The use of carrageenans in the 
encapsulation field has rarely related in the literature. Previous studies have reported 
on capsules produced by carrageenan and oligochitosan polymer [31], but concerning 
cell encapsulation the reports are only related to the use of carrageenan (in special k-
carrageenan) for the encapsulation of microbial cells [32, 33, 122].  
 
1.1.1.3 Alginate 
Alginate is a linear polymer of (1-4) - β -D-mannuronopyranosyl and (1-4)-  -L-
guluronopyranosyl units in a copolymer that contains homopolymeric sequences 
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(figure 1-6). They occur naturally as the major structural polysaccharides of brown 
marine algae (Phaeophyceae) [124, 125] and as extracellular mucilages secreted by 
certain species of bacteria (Azobacter Vinelandii) [30, 124]. 
 
 
Figure 1-6. Alginate structure. Adapted from [143]. 
 
Guluronic and manuronic acid contain negatively charged functional groups. As a 
result, these negatively charged regions within the alginate structure can parallel the 
electrostatic conditions created by sulphated proteoglycans in native tissue and might 
offer to some cells, such as chondrocytes, a more conductive environment [126] . 
Alginate remains the most widely used biomaterial for immobilizing cells, because 
of the many advantages it offers [127-129]. First, alginate has the capacity to gel under 
physiological conditions that are compatible with cell survival [128, 130]. The gelling 
reaction does not require toxic solvents and does not generate harmful by products. 
Second, the rapidity of the gelling process is a further critical advantage [128]. 
This polymer develops a simple and rapid gelation with divalent metal ions such as 
Ca2+, through binding of consecutives blocks of G-molecules on individual or different 
molecules [124, 131-133]. Therefore, many researchers used alginate as the matrix to 
prepare microcapsules to be used as an injectable cell delivery vehicle [134] and cell 
immobilization matrix [135-137], involving different cell sources such as myoblasts 
[138, 139], epithelial cells [139] hybridoma cells [8, 140], fibroblasts [134, 137], 
pancreatic islets [6, 134] and microbial cells [141, 142]. Additionally, alginate is 
relatively biocompatible and approved by the Food and Drug Administration (FDA) for 
human use as wound dressing material [1]. 
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As a natural polymer, alginate is limited by its tendency to be largely 
contaminated. Additionally, the industrial process used for extracting alginates from 
seaweed can introduce additional contaminants into the raw materials [128]. 
Consequently, the purity of the alginate has been found to be a pertinent factor in the 
biocompatibility of alginate [133]. For instance, when non purified alginate was used 
for islet encapsulation and transplantation into diabetic animals, a severe reaction 
against the microcapsule occurred immediately after implantation, and blood glucose 
was not normalized or was normalized only for a few days [128, 138]. On the other 
hand, alginate purification allowed the successful encapsulation and transplantation of 
islets, enabling the control of the levels of glucose in the blood of diabetic animals 
[128, 144].  
The presence of immunologic response can be partly for linking to β(1-4) glycosidic 
linkages, since other homopolymeric di-equatorial polyuronates, like D-glucuronic acid 
(C6-oxidized cellose), exhibit this feature. In vivo animal models have revealed the 
immunologic potential of polymannuronate in diverse areas for protection against 
lethal bacterial infections and irradiation, and for increasing non-specific immunity 
[124].  
Due to its interesting and promising properties, alginate was also studied in this 
thesis for the development of a novel encapsulation system. However, our aim was to 
combine this polymer with other (namely with carrageenan) in order to enhance the 
properties of this system as a cell encapsulation device, envisioning the future 
development of highly functional systems. 
 
1.1.2 PROCESSING AND FORMAT OF NATURAL POLYMERS 
Polymeric materials have been applied in many different biomedical applications, 
and therefore may be found in a variety of forms such as membranes, films, fibres, 
gels, hydrogels, capsules, spheres, particles and 3D-structures (scaffolds) (Figure 1-7). 
In fact, in most cases, the criteria for the design of the polymeric systems depend 
on the target application/site of implantation [4]. Careful design of the structure and of 
the interfacial properties of the matrix and its morphology and pore size are 
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particularly important for biomaterials used as cell-growth scaffolds, and as supports 
for immobilized biomolecules/cells [4, 145]. 
 
 
 
Figure 1-7. Some forms based on natural polymers that can be used in different biomedical applications, 
such as tissue regeneration and delivery systems. 
 
Others requirements and properties such as durability, elasticity, tensile strength, 
adhesion should be considered in polymers for using as sutures and long-term skin 
substitutes. Polymers for matrices or carrieres in controlled-delivery devices require 
the consideration of characteristics like molecular weight, adhesion and solubility, 
depending on the type of system, action and the target site in the body. Polymeric 
materials for drug delivery must satisfy additional requirements such as environmental 
responsiveness (pH or temperature dependent phase or volume transformation) [4, 
126]. 
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In this work, we have focused on three particular designs/formats, based on 
different polymers (Figure 1-8), that may found use in particular tissue engineering 
applications or in other cell based therapies. For this reason, in the next sections we 
will develop the description of membranes, 3D-porous scaffolds and capsules, their 
main applications, features, and processing methodologies. 
 
 
Figure 1-8. Schematic representation of the research approach followed in this thesis. 
 
1.1.2.1 Membranes 
Polymeric membranes have been developed for a variety of industrial applications 
such as microfiltration, ultrafiltration, reverse osmosis and gas separation [146, 147]. 
In biomedical applications, polymer membranes are used specially for skin 
regeneration, maxillofacial and pharmaceutical applications [126]. Each application 
needs to meet specific requirements regarding the material and structure [146]. The 
final morphology of the membranes obtained depends on the material properties and 
the processing conditions. The majority of membranes are prepared by methods based 
on a controlled phase separation of polymer solutions into two phases: one with a high 
polymer concentration and another with low polymer concentration [146]. Membrane 
systems prepared by this method take advantage of their selectivity, high surface-area-
per-unit-volume, and their potential for controlling the level of contact and/or mixing 
between two phases [147]. 
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Nevertheless, membranes can also be obtained by an interfacial polymerisation 
technique. In this case, the polymer is transformed in a controlled manner from a 
liquid to a solid phase. The concept of phase inversion involves a variety of different 
techniques such as precipitation by controlled solvent evaporation, thermal 
precipitation, precipitation from vapour phase, immersion precipitation, etc. [148]. 
Another method for preparing membranes is solvent casting, where the polymer is 
dissolved into a suitable organic solvent (e.g. chitosan can be dissolved into aqueous 
acetic acid) and then the solution is cast into a petri dish or into an appropriate mould 
[101] (Figure 1-9).  
 
 
Figure 1-9. Membrane prepared by solvent casting – schematic representation. 
 
Chitosan, for example is a polymer easily processed into membranes. In fact, 
chitosan membranes may be prepared by various ways such as evaporation of chitosan 
solvents, cross-linking with bifunctional reagents, chelating with anionic counterions or 
complexion with polymers and proteins [29]. Chitosan membranes have been used in 
several biomedical applications, such as controlled release [76, 149, 150], wound 
healing and surgical dressing [42, 151, 152]. In this work, solvent casting was the 
methodology used to obtain the chitosan based membranes. 
 
1.1.2.2 Scaffolds design and fabrication 
Three-dimensional (3-D) porous constructs have been one of the most widely 
studied scaffolds format in tissue engineering, as they provide the necessary support 
for cells to proliferate and maintain their differentiated function, and their architecture 
may define the ultimate shape of the new tissue to be formed, such as bone and 
cartilage [153, 154]. 
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Factors governing scaffold design are complex and include considerations of matrix 
architecture, pore size and morphology, mechanics versus porosity, surface properties 
and degradation rate [153, 155]. 
A number of fabrication technologies have been applied to process biodegradable 
and bioresorbable materials into 3-D polymeric scaffolds of high porosity and surface 
area. The conventional techniques for scaffold fabrication include fibre bonding [156, 
157], solvent casting [157-161], particulate leaching [162], gas foaming [163-165], 
phase separation/emulsification [166-169], membrane lamination and melt molding 
[153, 170]. Additionally, others methods include extrusion, in situ polymerization [73, 
171], 3D-printing and selective laser sintering [155, 172, 173]. Below some methods for 
scaffolds fabrication that were used in this thesis are described. 
 
Solvent-casting and particle leaching. The solvent casting and particle leaching is 
one of the most widely used methodologies to obtain scaffolds and membranes for 
biomedical applications. This method involves the use of a water soluble porogen, such 
as salt (NaCl) [159, 160, 174] to create pores. The solvent casting and particle leaching 
method consist in dispersing a sieved mineral (e.g. NaCl) or organic (e.g. saccharose) 
particles in a polymer solution [73]. This dispersion is then processed either by casting 
or by freeze-drying in order to produce porous bi and three-dimensional supports 
[175]. 
 
Freeze-Drying. The basic principle of the freeze-drying process relies on a 
thermally induced phase separation, which occurs when the temperature of a 
homogenous polymer solution, previously poured into a mould, is decreased. Once the 
phase-separated system is stabilized, the solvent-rich phase is removed by vacuum 
sublimation leaving behind the polymeric foam [175]. The foam morphology is of 
course controlled by any phase transition that occurs during the cooling step, i.e., 
liquid-liquid or solid-liquid demixing [175].  
In this work, chitosan based porous structures were produced by means of 
combining a sol-gel process and the freeze-drying technique. This technique has been 
used in previous studies by our group for the development of chitosan based porous 
structures, where the chitosan sol-gel was poured into a petri dish and allowed to dry 
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at room temperature for several days [102]. By its turn, the porous hybrids were 
obtained by transferring the sol-gel into a mould, freezing at -80⁰C overnight, followed 
by freeze-drying for several days to completely remove the solvent [102]. The 
properties, such as scaffold porosity, are controlled by several treatments including 
crosslinking, neutralization with alkali solutions and control of the pH of the initial 
polymeric solution [73]. 
 
1.1.2.3 Capsules 
Cell encapsulation technology is an exciting field of biotechnology that has 
emerged and developed rapidly in the past decade [176]. One of its strategies is cell 
microencapsulation, which aims to overcome the present difficulties relating to whole 
organ graft rejection and, consequently, the requirements for the use of 
immunomodulatory protocols or immunosuppressive drugs [136]. Therefore, cell 
microencapsulation has also raised much interest in part due to the advancement and 
optimization of the biomaterials used to develop the capsules [177]. 
Capsules in the 0.3-1.5 mm range have been traditionally refereed to as 
microcapsules in the cell encapsulation field. Their relatively small size is considered 
advantageous from a mass transport perspective. Microcapsules are typically more 
durable than macrocapsules and difficult to mechanically disrupt. Numerous 
microencapsulation techniques, different in the nature of entrapment mechanism, 
have been developed. Besides traditional capsules with a well-defined shell-and-core 
structure, encapsulation in microbeads without a distinct membrane has been 
successful used in some specific applications [133]. 
Some known methodologies for capsules formation namely, complex 
coacervation, coextrusion and emulsion, polyelectrolyte complex and ionotropic 
gelation [129] are described below. 
Coacervation: This methodology consists in using a system with some parameters 
such as temperature, pH, or composition, that can be adjusted in a liquid phase of pre-
membrane component separates from a polymeric solution and wraps the liquid core 
as a uniform layer. The liquid core droplet is caled “coacervate”. The pre-membrane 
component is solidified by means of heat, crosslinking, or solvent removal techniques. 
An hydrophilic pre-membrane component, such as gelatin and gelatin-gum acacia, is 
Chapter 1. Introduction 
Novel polymeric systems based on natural materials: 
development and biological performance 
 
18 
required for the encapsulation of citrus oil, vegetable oil, and water-soluble vitamins. 
When the core material is water soluble or immiscible, the pre-membrane component 
is hydrophobic. Coacervation is an efficient but expensive process [141].  
 
Emulsion/interfacial polymerization: In this method, interfacial polymerization 
occurs between monomers dissolved in the respective immiscible phases. Aqueous 
drops containing the water-soluble monomer are dispersed in the organic phase by 
stirring. The capsule membrane is then formed by adding the other organic solvent-
soluble monomer to the continuous organic phase [141]. 
 
Polyelectrolyte complex: This method is formed by mixing polysaccharides of 
opposite charge, with a high potential for using in drug delivery systems and as well as 
in various biological and biotechnological applications. The characteristics of the 
polyelectrolytes, such as charge density, chain conformation, response to variation in 
pH, ionic strength and temperature, offer a wide set of variables that can be use to 
tailor the capsules to be used in different applications such as pharmaceutical 
formulations and cell encapsulation [66]. 
 
Ionotropic gelation: This is a very mild process formed with a variety of 
counterions or polymers, such as alginate, carrageenan, carboxymethylcellulose, 
pyrophosphate, octylsulphate, etc. [29, 178], where, the counterion polymers are 
prepared by reacting the polymer with divalent ions such as calcium [29].  
 
1.1.2.4  Cell encapsulation methods 
Cell encapsulation technology has the potential to treat a wide range of diseases 
by the controlled and continuous delivery of biological products to the host [176]. The 
aim of encapsulation is the immunoisolation of cells (avoiding immunologic response). 
The technique consists on surrounding cells with a thin microporous semipermeable 
membrane. The principle of encapsulating cell is that the permeability of the 
membrane is engineered to allow the efficient passage of oxygen, important nutrients 
and cellular products [179]. 
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Many types of natural and synthetic polymers are being explored for cell 
encapsulation application, but the development of an ideal material to form a capsule 
is challenging. The majority of the literature describes the use of sodium alginate 
(polyanion) and poly-L-lysine (PLL-polycations) [136]. 
The polymers used for cell encapsulation must have specific characteristics such 
as, mechanical resistance, degradability, permeability, solubility and transparency [4, 
129, 136], but the currently available polymers need to be improved by altering their 
surface and bulk properties in order to meet those requirements. The design of 
macromolecules must therefore be carefully tailored in order to provide the 
combination of chemical, interfacial, mechanical and biological functions necessary to 
manufacture new and improved biomaterials [4, 129].  
Polyelectrolyte gels and polyelectrolyte complexes have played an important role 
in the microencapsulation of cells, with alginate and alginate/poly(L-lyine) complexes 
representing the most widely studied materials for these application. In the case of 
ionic cross-linking (figure 1-10), cells are first suspended in a polymer solution (e.g. 
sodium alginate), which is subsequently dropped into a receiving bath containing a 
multivalent cation (e.g. Ca2+, Ba2+) to create beads. This gentle gelation process is cell-
compatible. Additionally, a polycation is used to form the outer layer to the beads (e.g. 
chitosan, poly(L-lysine), which often provides additional mechanical integrity [178] to 
the capsules.  
 
 
Figure 1-10. Schematic representation of a typical encapsulation process involving ionic cross-linking of 
alginate. Adapted from [178]. 
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A wide variety of polyelectrolyte gels and complexes have been investigated for 
cell encapsulation. The Table 1-4 lists some physical characteristics of polyelectrolyte 
commonly used in cell encapsulation applications [178].  
 
Table 1-4. Characteristics of some polyelectrolytes used for cell encapsulation. Adapted from [178]. 
Polyelectrolyte Reported Characteristics Ref. 
Alginate 
Strong polyanion. In vivo and in vitro applications with 
long-term of cell viability. 
[124, 138, 
180, 181] 
Carrageenan 
Strong polyanion. κapa and ιota-carrageenan form 
thermoreversible gels on cooling in the presence of 
appropriate counterions. Microbial cell viability. 
[31] 
Poly (styrene sulphonate) 
Strong polyanion. A process for depositing alternating 
layers and microencapsulation. 
Cell viability and functionality was maintained.  
[182, 183] 
Carboxymethlcellulose 
Polyanion. A sign of insufficient biocompatibility was 
suppressed by altering the external surface material from 
Alg to CMC. 
[184] 
Cellulose sulfate 
Polyanion. Preclinical studies of the biological properties, 
being developed for use as a topical contraceptive 
antimicrobial agent. 
[26] 
Heparin 
Polyanion. Heparin is a highly sulfated glycosaminoglycan 
widely used as an injectable anticoagulant. It is also used 
to form an inner anticoagulant surface on various 
experimental and medical devices. 
[185, 186] 
Poly (methylene–co-
guanidine) 
Polyanion. Microcapsule has been developed based on 
the polyelectrolyte complexation which was successfully 
tested in rodent animal models. 
[187] 
Poly (diallyldimethyl 
ammonium chloride) 
Strong polycation. Microcapsules developed by 
polyelectrolyte complexes, suitable for the encapsulation 
of these biological substances. 
[188] 
Chitosan 
Weak polycation, pKa of primary amine 6.3-6.8 Polymer 
used for membrane’s capsules. 
[31, 189] 
Poly (L-lysine) 
Weak polycation, pKa of primary amine ~ 10.5 
A novel technique for creating supported lipid 
membranes on polyelectrolyte multilayers is described. 
Encapsulated CHO cells 90% viability. 
[190, 191] 
Poly (vinylamine) 
hydrochloride 
Weak polycation. Mechanically stable microcapsules 
have been produced for applications involving living cells 
and controlled delivery. 
[192] 
Poly (allylamine) 
hydrochloride 
Weak polycation, pKa of amine group ~ 8.5 
After encapsulation, cells preserve their metabolic 
activities and they are still able to divide. 
[182] 
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1.2 BIOCOMPATIBILITY 
 
One of the main aims of this thesis was to study the biocompatibility of chitosan 
based membranes and scaffolds as well as to assess the functionality i.e., the 
enhancement of cell adhesion on the surface of chitosan membranes due to several 
different plasma surface treatments. 
Therefore, in this section, it will be described the importance of biocompatibility 
testing and the main types of cytotoxicity/biocompatibility assays that can be used to 
assess the biological behaviour of materials being developed for biomedical 
applications. 
Biocompatibility of polymeric materials refers to the reaction of polymers with 
blood and tissue, depending on the site and purpose of use [126, 145]. 
Biocompatibility must be articulated within the context of an end-use application and 
has measurable dimensions only within this context [193]. 
The terms “biocompatibilty asesment” and “safety asesment” have ben 
generally considered to be synonomous. The safety assessment of biomaterials, 
prostheses, artificial organs and other medical devices generally is considered to be 
the determination of the biological interactions of the medical device in an in vivo 
environment [194]. The goal of safety testing is to evaluate if a medical device or 
biomaterial support presents potential harm to the patient or user under conditions 
simulating use. A broad definition of biocompatibility applied to tissue engineering 
implants includes the determination of the biological interactions of the device, i.e. 
biomaterial component, tissue component, and combination of biomaterial and tissue 
components, in an in vivo environment [194, 195]. 
One of the major problems in the use of polymers as biomaterials is to make sure 
that they are biocompatible by themselves, and that the use of particular additives 
and/or processing technologies required to obtain different properties and or 
configurations will not interfere with the biocompatible behaviour [196, 197]. 
In terms of biocompatibility, the requirements that degradable materials must 
fulfil are much more demanding than those for non-degradable materials. In addition 
to the potential problem of toxic contaminants leaching out from the implant, such as 
residual monomers, stabilisers, emulsifiers and many other types of additive, it is also 
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necessary to considerer the potential toxicity of the degradation products and 
subsequent metabolites [198]. Natural origin polymers, besides being biodegradable, 
present some characteristics that may affect their biocompatibility behaviour. 
In fact, these polymers usually contain domains that can send important signals to 
guide cells at various stages of their development [175, 199, 200]. However, this 
bioactivity can cause problems with antigenicity [175, 200], because when the material 
is implanted in a host, this might stimulate an immune response, potentially leading to 
immune rejection. Additionally, the degradation of natural polymers often relies on 
enzymatic processes that produce variation in the degradation rate. Nevertheless, 
natural origin polymers were the first to be used as scaffold materials for tissue 
regeneration [175, 200].  
 
1.2.1 IN VITRO CYTOTOXICITY/BIOCOMPATIBILITY ASSAYS 
Cytotoxicity testing represents the initial phase in testing the biocompatibility of 
potential biomaterials and medical devices. Its purpose is to act as a reliable, 
convenient, and reproducible screening method to detect, at an early stage in the 
testing process, cell death or other serious negative effects on cellular functions [201-
205]. 
The term “cytotoxicity” means to cause toxic efects (death, alterations in celular 
membrane permeability, enzymatic inhibition, etc.) at the cellular level. It is clearly 
different from physical factors that affect cellular adhesion (surface charge of a 
material, hydrophobicity, hydrophilicy, etc.) [206]. A toxic material releases a chemical 
in sufficient quantities to affect cells directly or indirectly through inhibition of 
metabolic pathways [206].  
Cytotoxicity in vitro assays are referenced in national and international standards 
[194, 206, 207]. Such methods can be applied to both direct and indirect testing 
assays. These assays differ mainly in the manner in which the test material is exposed 
to the cells. The choice of the method varies with the characteristics of the test 
material, the rationale for doing the test and the application of the data for evaluating 
biocompatibility [206, 208, 209]. Regarding indirect contact two methods can be 
considered [208, 209]. The first consists of the separation of the material from cells by 
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a diffusion barrier, such as an agar layer, place between the material and a cell 
monolayer. The second consists of the addition of an extract of the material to a cell 
monolayer. Indirect testing techniques are important for the detection of leachable 
substrates, which could exert toxic effects on cells [208]. Direct contact techniques 
involve assays in which the material to be tested is brought into direct contact with the 
cells, usually by seeding a cell suspension onto the material [208, 209] (Figure 1-11). 
 
 
 
Figure 1-11. Schematic representation of the set up for a Direct Contact Assay, where the cell 
suspension is seeded onto a membrane or scaffold materials. 
 
In the direct contact assay, the interaction cell-material is very important because 
this interaction allows the adherence and attachment of different cell types on the 
surface of the material (2D or 3D). 
Adhesion of cells (mammalian and microbial) to surfaces is a complex, multi-steps 
process. Initial bio-adhesive steps involve transport of the cells into the inter-phase 
that separates a surface from the suspending medium through mass-transfer 
processes, such as flow or gravitation [193]. 
 
1.2.1.1 Assessment of cell attachment and adhesion 
Cell adhesion is probably the single most important aspect of cell interaction with 
a biomaterial because it is a prerequisite for the further cellular functions such as 
spreading, proliferation, migration and biosynthetic activity [196, 208]. Indeed, surface 
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characteristics of materials (topography, chemistry, surface energy, wettability) play an 
essential role in cell adhesion onto biomaterials [4, 193, 196, 210]. 
Attachment is different than adhesion. Adhesion refers to the force necessary to 
separate adherents and is controlled by short-range forces resulting from the 
formation of covalent, ionic, hydrogen and charge-transfer bonds. Thus, adhesion 
occurs only if cellular surfaces (or some extension of the cell surface) touch the 
substratum so that atomic-level contacts can be made. In contrast, attachment can be 
of the physical kind in which cells are held in an attractive potential well near the 
substratum, formed through a conspiracy of electrostatic repulsion and dispersion 
force attraction. Attachment occurs first, then possible adhesion. Once attached to a 
substratum cells can spread and proliferate on this surface [193]. 
Initial cells/materials interactions can be characterized in four stages: 1) protein 
adsorption to the surfaces, 2) contact of rounded cells, 3) attachment of cell to the 
substrate, and 4) spreading of cells. Initial cell attachment depends mainly on the 
substrate characteristics and cell type [211, 212]. 
Diverse biological responses to materials, such as protein absorption and cell 
adhesion respond to local solvent properties of water against hydrophobic and 
hydrophilic surfaces [193]. In the case of protein as solute can be adsorbed to 
hydrophobic surfaces but not to hydrophilic surfaces, because surface dehydration is 
energetically unfavourable. Previous studies suggest that proteins can be associated or 
entrapped within bound-water layers against hydrophilic surfaces in a fashion that 
does not formally involve surface dehydration. Additionally, hydrophilic surfaces 
support attachment of mammalian cells and efficiently active the blood plasma 
coagulation cascade through mechanisms that apparently do not involve surface-
adsorbed protein [193].  
 
1.2.1.1.1 Surface treatment. The surface of biomaterials plays a vital role in biomedical 
applications. In the case of polymers, these often do not have the adequate surface 
properties for biomedical applications [213, 214], although, they have excellent bulk 
physical and chemical properties [214]. Therefore, polymers have been submitted to 
several treatments in order to enhance their properties, particularly to increase cell 
adhesion and proliferation onto their surfaces. In recent years, many advances have 
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been made in developing surface treatments to alter the chemical and physical 
properties of polymer surfaces without affecting bulk properties. Common surface 
modification techniques include treatments by flame, corona, plasmas, photons, 
electron beams, ion beams, X-rays, and -rays [214]. Plasma processes as surface 
treatment techniques are becoming more common in biomaterials engineering [210]. 
Plasma treatment is probably the most versatile surface treatment technique. 
Different types of gases such as argon, oxygen, nitrogen, fluorine, carbon dioxide, and 
water can produce the unique surface properties required by various applications 
[210, 214, 215]. For instance, nitrogen-containing plasma is widely used to improve 
wettability, bondability and biocompatibility of polymer surfaces. Ammonia and 
nitrogen plasma have been used to provide surface amino binding sites for 
immobilization of heparin on a variety of polymer surfaces [214]. In the biomedical 
area, plasma treatments have been used to modify biomaterials for various 
applications including devices or implants for diagnosis or therapy such as contact 
lenses, artificial heart valves, vascular grafts, catheters, dialysis membranes, prosthetic 
devices, and materials for bone joint repair and replacement [216]. 
Plasma deposition (including both grafting and polymerization) has been utilized to 
create a new surface chemistry for enhancing the culturing of cells on surfaces, for 
modifying protein and cell interactions, or to reduce surface friction and thereby 
enhance the biocompatibility of the material; to create a barrier film in order to reduce 
undesirable diffusion of small molecules into or out of the substrate (e.g. absorption 
from the environment and release of leachables from the substrate), or to control the 
rate of diffusion of drugs from the substrate; and to form reactive groups on the 
surface for subsequent immobilization of biomolecules or for grafting and 
polymerization with other chemical compounds [214, 217, 218]. The capability of 
plasmas to alter surface physical and chemical properties without affecting the bulk 
properties (especially mechanical properties) of the base material is advantageous in 
the design, development, and manufacturing of biocompatible polymers. By either 
surface modification or thin-film deposition, specific surface chemistries can be 
created for optimization of protein-surface interactions and therefore biocompatibility 
(especially blood compatibility) of biomaterials (Figure 1-12) Plasma etching 
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treatments are applied to biomedical material surfaces for sterilization, wettability 
improvement, providing reactive sites, and crosslinking surface molecules [214]. 
 
 
Figure 1-12. Possible processing procedures for plasma-induced chemical micropatterning. Adapted 
from [215]. 
 
Particularly in tissue engineering, as previously mentioned, it is often necessary to 
modify the surface of the scaffolds developed for cell attachment and growth. For this 
purpose, there are three basic approaches that can be considered (Figure 1-13). 
 
 
Figure 1-13. Approaches for enhancement of cell growth on surfaces. Adapted from [145]. 
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First, the surface tension may be adapted by adding chemical groups to the surface 
which lead to a defined hydrophilicity. Second, amine or carboxylic functions used to 
bond proteins or protein segments can be provided, so that the cells will not perceive 
the surface to be ‘foreign’. Third, so-called growth factors (cytokines) can be bonded 
to the surface, so as to accelerate cell growth. A cell growth improvement on a plasma-
treated technical material can be developed for various cell types, e.g. for skin cells 
(keratinocytes) or cornea cells of the eye. Possible applications are the production of 
artificial skin (e.g. for burn victims and in cosmetic tolerance analysis), artificial cornea 
cells can be used as a substitute for animal experiments [145]. 
In this work, and in order to improve cell adhesion and proliferation, surface 
modification of chitosan based membranes were carried out by plasma using gases 
such as nitrogen and argon.  
 
1.2.1.2 Relevance of in vitro testing and cell types used in biocompatibilty studies 
The major advantage of using in vitro methods for cytotoxicity/biocompatibility 
testing is their cost effectiveness and speed, which make them particularly suitable for 
screening large numbers of potential biomaterials and their modifications [204, 219]. 
Additionally, animal experiences are reduced. Coupled with this is the high sensitivity 
of the methods, which enables potentially cytotoxic materials to be identified at an 
early stage in the testing procedure [202, 220]. 
The fundamental problem of in vitro methods is the need to extrapolate to the in 
vivo situation [219, 221]. However, this connection is far to be established and thus it 
should be stressed that in vitro testing represents only one phase in assessing 
biocompatibility [221]. Specimens classified as in vitro biocompatibility must enter a 
further phase of testing, which requires in vivo observation [222]. 
Cell culture methods have been used to evaluate the biological compatibility of 
materials for more than two decades. Most of the cells used for culture assays are cell 
lines previously established that can be purchased from biological suppliers or cell 
banks. These cells offer higher reproducibility, efficiency and in some cases availability 
in comparison with primary cells or other cell types [206].  
Cell lines have been developed for growth in vitro. The use of these cells in 
biocompatibility tests is preferred to primary cells (that are freshly harvested from live 
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organisms) because the cell lines improve the reproducibility of the assays and reduce 
the variability among laboratories. Additionally, cell lines maintain their genetic and 
morphological characteristics throughout a long life period [206]. However, the use of 
a cell line can be considered partially transformed cells with a predisposition to 
become fully neoplastic cells capable of forming tumours in the recipient [211]. 
The L-929 mouse fibroblasts cell (Figure 1-14, C-D) has been one of the most 
extensively used for testing biomaterials. Initially, L-929 cells were selected because 
they were easy to maintain in culture and produced results that had a high correlation 
with specific animal bioassays. Furthermore, fibroblast was chosen because it is one of 
the early cells to populate a healing wound and is often the major cell in the tissue that 
attaches to implanted medical devices [206, 223]. Cells lines from other tissues or 
species may also be used such as SaOS-2 Human osteosarcoma cell line [224] (Figure 
1-14, A-B), ATCC murine hybridoma cell line HB121 [140], 1B5 hybridoma cell line [8], 
MDCK cells and canine renal epithelial cell line [139], etc. Selection of a cell line is 
based mainly on the type of assay, type experience and specific end application, 
among others various factors. Positive and negative controls are often included in the 
assays to ensure the operation and suitability of the test system [206].  
 
Figure 1-14. Morphology of some cell lines used in biocompatibility tests. A and B images showed SaOS-
2 cell line; C and D images showed L929 cell line. All photos were taken using inverted microscope using 
the objectives 10X (left images) and 20X (right images).  
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CHAPTER 2 
 
2 MATERIALS AND METHODS  
This thesis comprise two major studies, the first corresponds to the study of the 
biocompatibility of chitosan membrane and scaffolds and the second to the 
development of a new cell encapsulation system based on alginate and carrageenan 
polymers. This chapter describes, in more detail, the materials and techniques used. 
 
2.1 MATERIALS DEVELOPMENT AND PREPARATION 
2.1.1 CHITOSAN MEMBRANES 
The chitosan membranes studied were obtained by solvent casting technique as 
described previously [1]. Briefly, Chitosan (powder) were dissolved in aqueous acetic 
acid 2% (v/v) solution at a concentration of 1% wt. Then the chitosan solution was 
casted into a Petri dish and dried at room temperature for about 6 days. In order to 
neutralize the acetic acid, the dried membranes were immersed in 0.1 M sodium 
hydroxide for about 10 min, and then washed with distilled water to remove all traces 
of alkali, followed by drying at room temperature. The developed membranes were 
then submitted to plasma surface treatments, performed under different conditions, 
in order to select the parameters that lead to best results in terms of improving cell 
adhesion and proliferation. The plasma treatment was carried out on a plasma 
reaction equipment (PlasmaPrep5, Germany), using a power of 20 W. The duration of 
the glow discharge treatment was varied from 10 min to 40 min, using nitrogen and 
argon gas. The plasma conditions tested and the correspondent samples designation 
used are presented in Table 2-1. Untreated chitosan membranes were used as control 
and designated by Cht.  
 
All the membranes submitted to plasma surface modification 
treatments were cut into squares of 1x1 cm2 and sterilized by 
ethylene oxide prior to all the biological studies performed. 
Figure 2-1. Chitosan membrane 
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Table 2-1. Plasma conditions used to treat the surface of chitosan membranes 
Sample 
Conditions 
Power 
[watts] 
Time [min] Gas 
ChtP1 20 10 Nitrogen 
ChtP2 20 20 Nitrogen 
ChtP3 20 30 Nitrogen 
ChtP4 20 40 Nitrogen 
ChtP5 20 10 Argon 
ChtP6 20 20 Argon 
ChtP7 20 30 Argon 
ChtP8 20 40 Argon 
 
2.1.2 CHITOSAN SCAFFOLDS 
The chitosan scaffolds studied in this thesis were developed by means of 
combining a sol-gel process and the freeze-drying technique described previously [2, 
3]. Briefly, the chitosan powder (Sigma, Portugal) was dissolved in acetic acid 2 % (v/v) 
at a concentration of 4 % wt. The obtained chitosan solution was poured into a Petri 
dish and allowed to dry at room temperature for several days. By its turn, the porous 
hybrids were obtained by transferring the mixture into silicon cilindrical moulds, 
freezing at -80 ⁰C overnight, followed by free-drying for the period of 4 days to 
completely remove the solvent [2]. The scaffolds were neutralized with sodium 
hydroxide (NaOH, Panreac) solution for 10 min and washing abundantly with distilled 
water until reaching the pH 7.0. Afterwards the scaffolds are placed again in the 
freezing at -80⁰C overnight, folowed by fre-drying for the period of 2 days [2]. Table 
2-2, showed the conditions used in the preparation of the several chitosan porous 
scaffolds formulations. After samples processing, the scaffolds were cut into cylinders 
of 0.6 cm (b) x 0.3 cm (h) x 0.25 cm (r) and sterilized by ethylene oxide prior to testing 
(Figure 2-2). 
 
Table 2-2. Conditions used in the preparation of the several chitosan porous hybrid scaffolds 
Sample polymer (g) 
TEOS:HCl 
(wt%) 
CaCl2 (g) 
Reaction time 
(hours) 
CT5 79.2 0.1:0.1 - 72 
CT6 79.2 0.1:0.1 0.0788 72 
CT7 79.2 0.1:0.01 - 72 
CT8 40 0.1:0.1 - 24 
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Figure 2-2. Chitosan scaffolds 
 
2.1.3 DEVELOPMENT OF CARRAGEENAN AND ALGINATE BASED MICROCAPSULES 
2.1.3.1 Development of microcapsules based on iota and kappa-carrageenan 
The microcapsules based on iota (Sigma, Portugal) and kappa-carrageenans 
(Sigma, Portugal) were developed from a pair of oppositely charged polysaccharides. 
For this purpose, 1 ml of an 1.5 % aqueous solution of iota (or kappa)-carrageenan was 
added drop by drop through a 0.3 mm needle (BD-Microfine U-100 insulin, Portugal), 
using a syringe pump (AL-1000, Aladdin Programmable Syringe Pump) into 20 ml of an 
0.15 % chitosan low molecular weight solution (0.0085 M HCl, Aldrich, Portugal). Both 
polysaccharides were dissolved in distilled water [4]. Capsules were also obtained 
using chitosan solutions at two diferent pHs (5.0 and 6.0) previously adjusted with β-
Glycerophosphate (β-GP, Sigma-Portugal) [5] as described below. 
The resulting capsules were allowed to harden for 45 min at 37 ⁰C (in a water 
bath), washed with 0.9 % NaCl and immersed in a 0.05% iota-carrageenan solution for 
5 minutes in order to link the remaining residues of chitosan. Finally, the capsules were 
rinsed twice with PBS and stored at 4 ⁰C in the same buffer (Figure 2-3). 
 
Adjustment of the pH of the chitosan solution using β-glycerol phosphate 
Chitosan solutions, with different pHs were used in order to form different types of 
capsules by polyelectrolyte complex and ionotropic gelation method [6]. In both 
methodologies, chitosan solution was used as polycation to obtain the membrane of 
the capsule at two different pHs: pH 5.0 and pH 6.0. Previous studies have 
demonstrated that chitosan can be neutralised up to physiological pH (7.2) using β-
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glycerol phosphate (β-GP), without promoting the precipitation of the polysaccharide 
[5, 7]. 
 
Figure 2-3. Graphical representation of the procedure used for the capsules development using 
oppositely charged polysaccharides (carrageenan as polyanion and chitosan as polycation). 
 
A curve of the variation of the pH in chitosan solution as function of β-GP 
concentration was drawn to determine the corect amount of β-GP to be added to 
reach the desired pH. For this purpose, a solution containing 0.0266 g/ml of β-GP was 
slowly added to a chitosan solution (0.30 % in 0.017 M HCl) until physiological pH. At 
this point (pH = 7), it was observed precipitation. The obtained curve is presented in 
Figure 2-4.  
 
2.1.3.2 Development of sodium alginate/iota- carrageenan microcapsules 
Microcapsules based on iota-carrageenan and alginate were developed by an 
ionotropic gelation method that was originally developed for the preparation of 
alginate capsules [6, 8, 9]. The procedure starts with the preparation of an aqueous 
sodium alginate/iota-carrageenan mixture composed of 1.5% aqueous solution of each 
polymer, at two different ratios, namely 50/50 % and 30/70 % (v/v), in order to 
determine the best formulation. Then, 1 ml of this mixture was extruded through the 
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0.3 mm needle, using a syringe pump, into 20 ml of a solution composed of 0.05 M 
CaCl2 and 0.2 M NaCl. All solutions were prepared in distilled water. 
 
0 2 4 6 8 10
2
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7
8
p
H
B-GP/Chitosan g/g
 
Figure 2-4. Variation of the pH relative to amount of β-GP with respect to chitosan (weight β-GP/weight 
chitosan g/g), at room temperature 
 
The resulting microcapsules were allowed to harden for 30 min at 37 ⁰C. 
Afterwards, the capsules were immersed in 20 ml of a 0.15 % (w/w) chitosan low Mw 
solution (in 0.0085 M HCl) at two pHs (pH 5.0 and 6.0) previously adjusted with β-
glycerophosphate (as was describe in section 2.1.3.1) for 20 min at 37 ⁰C. After this, 
the capsules were rinsed with PBS for 1 min and immersed in a 0.05% iota-
carrageenan for 5 minutes. Microcapsules with liquefied/depolymerised core also 
were prepared using a sodium citrate (a calcium sequestering agent) treatment. This 
treatment consisted in the immersion of the obtained iota-carrageenan + alginate 
microcapsules in a 0.055 M solution of sodium citrate for 1 min [10, 11]. Finally, the 
obtained capsules (solid and liquefied) were rinsed twice with PBS buffer and stored at 
4⁰C in the same bufer for posterior characterization (Figure 2-5). Another batch of 
capsules were immersed in DMEM to assess the stability of the microcapsules in 
culture medium and also to observe the permeability of the culturing medium into the 
capsules. 
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Figure 2-5. Graphical representation of capsules produced by ionotropic gelation method 
 
2.1.3.3 Cell encapsulation studies 
Immobilisation of the cells was performed using a L929 fibroblasts cell line in 
sodium alginate/iota-carrageenan capsules (solid and liquefied beads). Microcapsules 
and cell encapsulation procedures were carried out at room temperature under sterile 
conditions, in a laminar flow cabinet. All solutions were prepared in distilled water and 
filtered using a membrane filter of 0.2 µm (Schleicher & Schuell Microscience, 
Germany). Before using in cell encapsulation experiments, the sodium alginate, iota-
carrageenan and chitosan solutions were autoclaved. The fibroblasts cells were initially 
harvested from monolayer using trypsin-EDTA (Invitrogen, Portugal), and a cell 
suspension containing a know amount of cells was prepared. The cells (5x103 cells per 
ml) of the polymeric solution were then mixed with the sodium alginate + iota-
carrageenan solution (30/70%). The cells-polymeric solution suspension was extruded 
into a calcium chloride-sodium chloride (CaCl2-NaCl), solution, as described above 
(section 2.1.3.2) using a syringe pump. The resulting microcapsules/cells were 
maintained in CaCl2-NaCl for 30 min at 37 ⁰C in a 5 % CO2 incubator. Afterwards, the 
capsules containing the cells were immersed in 20 ml of 0.15 % (w/w) chitosan low Mw 
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solution (in 0.0085 M HCl) at pH 5.0 for 10 min and at 37 ⁰C. After this, the capsules 
were rinsed with PBS for 1 min and immersed in 0.05% iota-carrageenan for 5 minutes. 
To obtain the liquefied capsules, the microcapsules with cells were treated with 0.055 
M of sodium citrate for 1 minute. Finally, microcapsules with cells were washed twice 
with PBS, transferred to several wells of a 6-well culture plate, and immersed in culture 
medium (Figure 2-6). The encapsulated cells were cultured in a 5 % CO2 incubator for 
different periods of time, namely 1, 2, 3 and 7 days. The culture medium was carefully 
changed every 2 days. 
 
 
Figure 2-6. Graphical representation of the cell encapsulation procedure carried out using the ionotropic 
gelation method. 
 
2.2 CELL CULTURE STUDIES 
2.2.1 CELLS USED 
For most of the cytotoxicity/biocompatibility tests performed, it was used the 
mouse lung fibroblast (L929) cell line, obtained from the European Collection of Cell 
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Cultures (ECC, UK). This cell line was grown as a monolayer cultured in 75 cm2 culture 
flasks, using Dulbeco’s Modifed Eagle’s Medium-low glucose (DMEM; Sigma-Aldrich, 
Portugal), supplemented with 10 % foetal bovine serum (FBS; Biochrom AG; Germany), 
1 % antibiotic/antimycotic (Invitrogen, Portugal) and sodium bicarbonate (Sigma, 
Portugal) at 37 ⁰C in a 5 % CO2 incubator [12]. The culture medium was changed every 
2 days and cells were grown until confluence, before starting each in vitro test. This 
cell line was selected for these studies because it is commonly used for cytotoxicity 
assessments related with biomaterial applications [12-18] as these cells are able to 
maintain their phenotypic characteristics for long periods in culture [19]. 
Further studies, namely for the assessment of cell adhesion and proliferation on 
chitosan scaffolds, it was used a cell line of osteoblastic like cells-SaOS (human 
osteosarcoma), obtained from European Collection of Cell Cultures (ECC, UK). As for 
the L929 cell line, SaOS cells were grown as monolayer in cell culture flasks using 
DMEM, supplemented with 10 % FBS and with 1 % of antibiotic/antimycotic mixture, 
and trypsinized prior to use. The chitosan scaffolds are aimed to be applied in bone 
tissue engineering and, for this reason, we have selected these cells. Previous studies 
have shown that these cells express the same range of extracellular matrix proteins as 
native osteoblasts [20, 21]. 
 
2.2.2 CYTOTOXICITY TESTING  
Cytotoxicity testing represents the initial phase in testing biocompatibility of 
potential biomaterials and medical devices [22-27]. For this work, the cytotoxicity of 
leachables of some biomaterials was evaluated using two cell culture methods, namely 
MEM extraction test (Minimum Essential Medium, 72 h-short term) and MTT test (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, both carried out after a 24 
hours extraction period, according to protocols described in ISO/EN 10993 [28]. Latex 
rubber (Dermagip, WRP) was used as a positive control and standard culture plates 
(Costar 96 well plates) were used as negative control. The biocompatibility of the 
chitosan membranes was assessed using the MEM and MTT test and the cytotoxicity of 
sodium alginate/iota-carrageenan capsules was evaluated by MTT test. 
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2.2.2.1 Extraction Procedures 
The extracts of materials (and positive control material), were obtained by 
immersion of materials in culture medium for 24 hours at 37 ⁰C, 60 rpm. In the case of 
chitosan membranes, 60 samples of 1 cm2 (of each formulation) were immersed in 50 
ml sterile tubes containing 10 ml of culture medium (DMEM-the same used for cell 
culture) and placed in a water bath at 37 ⁰C and 60 rpm for 24 hours (Figure 2-7). In 
the case of the microcapsules, the extracts materials were obtained by immersion of 
100 microcapsules (of each type) in a sterile tube containing 5 ml of DMEM and placed 
in a water bath at 37 ⁰C and 60 rpm for 24 h. In both cases, latex rubber was used as 
positive control, where the latex extracts were obtained by immersing 60 latex squares 
of 1 cm2  in sterile tubes containing 10 ml of DMEM, following the same procedure as 
described for obtaining the membranes and capsules extracts. After the 24 h 
extraction time, the tubes were removed from the water bath and their content 
(extract material) was filtered using a membrane filter of 0.45 µm (Schleicher & Schuell 
Microscience, Germany) and transferred to new sterile tube. 
 
 
Figure 2-7. Graphical representation of the procedure used to prepare extracts of the chitosan 
membranes 
 
2.2.2.2 MEM extraction test (72h) 
The MEM (Minimum Essential Medium) extract test is a cytotoxicity test that has 
as main objective evaluating qualitatively the rates of cell damage (change of cellular 
morphology, inhibition of cell growth, cellular lysis and confluence of monolayer). 
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For this test L929 cells were seeded in 6-well plate (n = 3) at a density of 
approximately 4.5 x 104 cell/ml when the cells reached about 80 % confluency (after 24 
h of culture). The culture medium in each well was replaced by 2 ml of extraction fluid 
and the response of the cells was evaluated for 72 h. Morphological characteristics 
were evaluated after 24, 48 and 72 hours using an inverted light microscope (Zeiss, 
Axiovert 40 CFL, 459306), and compared to the negative and positive control. The 
observations based on the confluency of the monolayer, degree of floating cells and 
changes in cellular morphology were scored, according to the parameters defined in 
Table 2-3 and as it has been reported in previous studies carried out in our group [12-
14, 29].  
After 72 h testing, the cells were detached from the culture wells by means of 
trypsinization. The percentage of growth inhibition was determined by cell counting, 
using a Neubauer camera and scored after correction for the value of the negative 
control. Addition of these two scores results in the final cytotoxicity response index 
ranging form 0 to 8 (see scores on Table 2-4) [12-14, 29]. 
 
Table 2-3. Scoring for morphological changes, confluence and cell death, used in the cytotoxicity tests 
Score 
Confluency 
[%] 
Floating cells 
[%] 
Change of cellular morphology 
Inhibition of 
cell growth [%] 
0-1 100 0 No changes during test period 0-10 
1-3 90-100 0-5 Slight changes, few cells affected 10-30 
3-5 60-90 5-10 Mild changes some cells round/spindle shaped 30-50 
5-7 30-60 10-20 Moderate changes, many cells round/spindle 50-70 
7-8 
0-30 >20 
Severe changes, about all cells show morphological 
changes 
70-100 
 
Table 2-4. Cytotoxicity indexes used to classify the reactivity of tested samples - cytotoxic response 
Cytotoxic response Reactivity Pass/fail 
0-1 None Pass 
1-3 Slight toxic Pass 
3-5 Mild toxic Retest 
5-7 Moderate toxic Fail 
7-8 Severe toxic Fail 
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2.2.2.3 MTT test 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-Sigma), is 
a yellow vital dye that is actively converted into blue formazan crystals by 
mitochondrial oxidation-reduction reaction. The formation of the blue formazan 
crystals formed within the cells is directly proportional to the viability of the cells [30]. 
The crystals formed intracellularly were dissolved by isopropanol [31]. 
In the MTT test, fibroblasts cells were seeded in 96-well plates (n = 6), at density of 
approximately 6.6 x 104 cell/ml after reaching about 80% of confluence (after 24 h of 
culture) and the culture medium in each well was replaced by 150 µl of extraction fluid 
(membranes extracts or capsules extracts) and the response of the cells was evaluated 
for 72 h. After this time, MTT solution was prepared (1 mg MTT/ ml in DMEM without 
red phenol and FBS) and 50 µl of this solution was added to the culture wells. The 
cultures were then incubated for 4h at 37 ⁰C in the dark. Following this time, the MTT 
solution was removed and replaced by isopropanol (100 µl) for 15 minutes, in order to 
lyse the cells (the purple solution appeared). Finally, the optical density (OD) was 
measured in a microplate reader (BIO-TEK – Synergy HT) at 570 nm with a background 
correction of the OD at 650 nm [14]. The evaluation expresses the variation of the 
absorbance in function of the concentration of extracted material. The results were 
expressed as percentage of cell viability. 
 
2.2.2.4 MTS test 
Cellular viability and proliferation in chitosan based membranes and sodium 
alginate/iota-carrageenan capsules were assessed by the MTS using CellTiter 96  one 
cell proliferation assay (Promega, Madison, USA). The MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) test has been 
described previously [15, 16, 32]: the substrate-MTS is bio-reduced into a brown 
formazan product by dehydrogenase enzymes, which are active in living cells. The 
intensity of the colour is directly related to the number of viable/living cells [15, 16]. In 
this study the MTS solution was prepared with DMEM without phenol red and FBS in a 
5:1 ratio, where 300 l of MTS solution was added to membranes/cells and incubated 
for 3 hours at 37 ⁰C in an atmosphere containing 5% of CO2 in the dark. To assess the 
viability of cells encapsulated into alginate/carrageenan capsules, 200 l of MTS 
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solution was added to the capsules with cells (3 per 96 well-culture plate) and 
incubated for 3 hours at 37 ⁰C, 5% CO2 in the dark. In both cases, after incubation 
period, 100 l of solution obtained from each membrane and capsules, were 
transferred to 96-well plates (in triplicate). The absorbance was read in a microplate 
reader (BIO-TEK – Synergy HT) at 490 nm. The results were expressed as absorbance 
obtained for the samples, in each culture period. 
 
2.2.2.5 Direct Contact assay 
The Direct Contact assay was used to evaluate the cell adhesion and cell 
proliferation on the surface of chitosan based membrane treated by plasma. For this 
purpose, L929 fibroblast cells were initially harvested from monolayer cultures using 
trypsin-EDTA. A cell suspension was prepared in order to obtain a cell density 8 x 104 
cells/cm2 [33]. The membranes were placed in 24 well plates and 100 µl of this cell 
suspension was seeded onto the samples surface (1x1 cm2) (Figure 2-8). Empty wells 
and coverslips (Sarstedt, USA), were also seeded with the same amount of the cell 
suspension to be used as controls. All the seeded samples and controls were incubated 
for 2-3 hours at 37 ⁰C in an atmosphere containing 5% of CO2. After this time, 1.5 ml of 
DMEM culture medium was added into each culture well and the samples cultured for 
different periods of time (3, 7 and 14 days). The culture medium was changed every 
two days.  
 
 
Figure 2-8. Graphical representation of the procedure used for cell seeding onto chitosan membranes 
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2.2.2.6 SEM analysis 
Cell adhesion was assessed by SEM (scanning electron microscope) for all the 
tested chitosan based materials. This technique is particularly useful to observe cell 
adherence and morphology in the different substrates. In the case of chitosan based 
membranes, after each culturing period, the chitosan membranes were removed from 
culture and washed with PBS, before being dehydrated using an increased 
concentration series of ethanol solutions (25%, 30%, 50%, 70%, 80%, 90% and 100% - 
each 30 min). The membranes were then dried at room temperature (in the laminar 
flow chamber) and sputter coated with gold before observation in a scanning electron 
microscope (SEM-Leica Cambridge S360). 
 
2.2.3 CELL SEEDING/CULTURING ONTO SCAFFOLDS 
Osteoblasts cells were harvested before reaching confluence from 75 cm2 culture 
flasks using trypsin-EDTA (Invitrogen, Portugal), re-suspended in 5 ml DMEM culture 
medium and centrifuged. A cell suspension was prepared in order to seed 5 x 105 cells 
per sample. The scaffolds were placed in 48 well non-adherents culture plates. For 
each different formulation 6 samples were used and 300 µl of cell suspension was 
seeded onto the surface of each scaffold (Figure 2-9). The culture plate was transferred 
to the incubator for 3 hours at 37 ⁰C in an atmosphere containing 5 % of CO2. After this 
time, 1 ml of DMEM culture medium was added into each well and the samples 
cultured for different periods of time (3, 7 and 14 days). The culture medium was 
changed every two days.  
For DNA and ALP analysis, the end of each culturing period, a batch of the scaffolds 
were washed twice with PBS and transferred to 15 ml tubes containing 1 ml of 
ultrapure water. Afterwards the samples were placed in a water bath at 37 ⁰C for 1 
hour (to enable the lyse of the cells). Finally, the tubes/scaffolds were frozen at – 80 ⁰C 
until testing. The remaining scaffolds were further treated for SEM observations. 
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Figure 2-9. Graphical representation of the procedure used for cell seeding onto chitosan scaffolds 
 
2.2.3.1 DNA quantification in lysed cells 
The DNA content of each scaffold was measured using a Picogreen® dsDNA 
Quantitation Kit (Invitrogen/Molecular Probes) [34]. PicoGreen® dsDNA quantitation 
reagent is an ultrasensitive fluorescent nucleic acid stain for quantify double-stranded 
DNA (dsDNA) in solution [35].  
For the DNA quantification in scaffolds, the samples were defrosted using 
ultrasound bath for about 15 minutes. Afterwards, 28.7 µl of sample or standard + 71.3 
µl of PicoGreen solution and 100 µl 1X TE (n = 4) were mixture using 96 culture plates 
(white opaque). The standard solutions were prepared according to the concentrations 
defined in Table 2-5. Then, the culture plates were incubated in the dark for 10 
minutes. The fluorescence was read in the microplate reader at 485/20nm for 
excitation and 528/20 nm for emission. DNA concentration was read from standard 
graph. Table 2-5 showed the standard solution preparation. 
The DNA quantification of each scaffold was calculated by correlation with the 
DNA of a known amount osteoblasts (SaOS) [36].  
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Table 2-5. Preparation of standard solutions - DNA assays 
Concentration Solution 
0.0 1000 l ultra pure water 
0.2 2 l standard + 1 ml ultra pure water 
0.3 3 l standard + 1 ml ultra pure water 
0.5 5 l standard + 995 l ultra pure water 
1.0 10 l standard + 990 l ultra pure water 
1.5 15 l standard + 985 l ultra pure water 
2.0 20 l standard + 980 l ultra pure water 
 
2.2.3.2 Alkaline phosphatase (ALP) assay 
ALP is an enzyme secreted from osteoblasts. It is thought to promote crystal 
formation in matrix vesicles by removing nucleation inhibitors. It is inhibited by 
glucocorticoids and parathyroid hormone (PTH) [37]. In the present study, ALP activity 
was quantified in osteoblasts cells to evaluate cell proliferation and differentiation on 
chitosan scaffolds, as the metabolic process of osteoblasts generally implies alkaline 
phosphatase activity and other marker for specific protein expression [38]. 
For this work, the ALP activity was measured using a Sigma Diagnostic kit [34], 
where alkaline phosphatase activity from de scaffolds/cells was quantified by the 
specific conversion of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP).  
For the ALP quantification in scaffolds, the samples were prepared as describe in 
DNA assays, where the tubes/scaffolds were defrosted using ultrasound bath for about 
15 minutes. Following this, from each tube it was taken 20 µl of sample solution and 
added to a 96 well culture plate (n = 4). Then, 60 µl of substrate solution ALP (p-
nitrophenyl phosphate -pNPP) was mixed. The 96 well plate was incubated at 37⁰C for 
45 minutes in the dark. After this period the reaction was stopped using 80 µl of stop 
solution and then the standard solutions were placed in the same 96 well plate (the 
standard solutions were prepared according to the Table 2-6). The absorbance was 
determined at 405 nm using the microplate reader [16, 34]. Product concentration was 
read from standard graph. The results were expressed in pNP produced by 
scaffold/day of cell culture. 
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Table 2-6. Preparation of standard solutions - ALP assays 
pNP Stock solution Stop solution [µl] 
Standard concentrations 
[µmol/ml] 
0.0 160.0 0 
0.8 159.2 5 
1.6 158.4 10 
2.4 157.6 15 
3.2 156.8 20 
 
2.2.3.3 SEM analysis of the cell seeding scaffolds 
The chitosan scaffolds were prepared as was described in section 2.2.2.6 for SEM 
observations. 
 
2.2.4  CELL VIABILITY OF ENCAPSULATED CELLS USING FLUORESCENT STAINS 
Two fluorescent dyes were used to assess the cellular viability in encapsulated 
cells, namely: Calcein-AM (Invitrogen) and DAPI (Sigma). 
 
Calcein-AM or acetoxymethyl ester of calcein, is a green-fluorescent dye widely 
used in cytotoxicity and cell viability assays, because it is easy to load and well retained 
in live cells [39, 40]. The Calcein-AM goes through the cell membrane of viable cells 
and is hydrolyzed by esterases into the cytoplasm demonstrating the cell viability. 
Calcein does not inhibit any cellular functions such as proliferation or chemotaxis of 
lymophocyte [41]. The amount of Calcein, hydrolyzed by esterases in cells is directly 
proportional to the number of viable cells in culture media. The esterases and phenol 
red in the culture medium interfere with the fluorescence measurement due to the 
cell culture medium is replaced by PBS. The excitation and the emission wavelengths of 
Calcein are 485 nm and 535 nm, respectively. An incubation of 10 to 30 minutes gives 
sufficient fluorescence intensity for the cell viability determination [42] (Figure 2-10).  
 
DAPI or 4’-6-diamidino-2-phenylindole, is a blue fluorescent stain known to form 
fluorescent complexes with natural double-stranded DNA, showing a fluorescence 
specificity for AT (Adenine-Timine) and AU (Adenine-Uracil) [43]. DAPI as same as 
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Calcein-AM passes through an intact cell membrane and it may be used to stain live 
and fixed cells. For fluorescence microscopy, DAPI is excited with ultraviolet light. 
When bounded to double-stranded DNA, 358 nm is the maximum absorption and 461 
nm is the maximum emission maximum (this emission is fairly broad, and appears 
blue/cyan) [44, 45].  
 
 
Figure 2-10. Graphical representation of cell fluorometric determination of living cell using Calcein-AM. 
Adapted from [41, 42]. 
 
In this work, the capsules (containing cells) were placed in an eppendorf tube 
containing 1 ml of DMEM and 2 µl of Calcein-AM and incubated for 20 min at 37 ⁰C in a 
5 % CO2 incubator. Afterwards, the capsules were rinsed in DMEM culture medium, 
and then in a PBS solution. The PBS was replaced by 500 µl of glutaraldehyde (2.5%) 
for 10 minutes at room temperature to fix the cells. Then, glutaraldehyde was 
removed and the capsules were rinsed twice in PBS. New PBS solution (1 ml) and 2 µl 
of DAPI were added for 20 minuntes at 37 ⁰C in a 5 % CO2 incubator. Finally, the 
capsules were rinsed twice in PBS and observed under a fluorescence microscope 
(Zeiss 434301) using Alexa Flour 488 and DAPI 49 (Molecular Probes). All the procedure 
was performed in the dark, protecting the samples from light (Figure 2-11). 
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Figure 2-11. Graphical representation of the procedure used for Calcein – DAPI fluorescescent staining 
to assess the viability of encapsulated cells 
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CHAPTER 3 
 
3 CELL ADHESION AND PROLIFERATION ONTO CHITOSAN BASED 
MEMBRANES TREATED BY PLASMA SURFACE MODIFICATION 1 
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Abstract 
Surface properties play a vital role in the functioning of a biomaterial. Cellular 
adherence and growth can be enhanced in biomaterials thought modifications of their 
surface. In this study it was evaluated the cellular response onto chitosan membranes 
surface modified by nitrogen and argon-plasma treatments. Chitosan is a natural origin 
polymer that exhibits suitable properties for biomedical applications such as 
biocompatibility and degradability. However, this polymer has shown smaller tendency 
for cell attachment and proliferation, which is critical in many applications. Therefore it 
is very important to develop techniques such as surface modifications treatments that 
have the ability to enhance cell adherence. In this work it was assessed the biological 
behaviour of chitosan membranes surface modified by argon and nitrogen-plasma 
treatments performed under different conditions. 
Possible cytotoxicity effects of material’s leachables were asesed using MEM and 
MTT assays. Cell attachment and proliferation onto membranes surface were 
evaluated analyzing the morphology of the cells by scanning electron microscopy and 
optical microscopy imaging, and cellular viability/proliferation using the MTS test. 
                                                      
1
 The present chapter is based on the following paper: S.M. Luna, S.S. Silva M.E. Gomes, J.F. Mano, R.L. Reis. “Cel adhesion and 
proliferation on chitosan based membranes treated by plasma surface modifcation”. Submitted to Journal of Materials Science: 
Materials in Medicine, 2007. 
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L929-fibroblasts cell line was used in all in vitro assays. The results showed that the 
extracts of membranes surface modified under all tested conditions (leachables) do 
not induce any cytotoxic effects. In general, it was evident an higher adhesion, 
attachment and proliferation of the L929 fibroblasts on treated membranes as 
compared to the untreated chitosan membranes. Nitrogen and argon-plasma 
treatment improve the surface characteristics of chitosan membranes by means of 
enhancing the levels of oxygen and nitrogen. The results obtained clearly 
demonstrated that plasma treatments constitute an effective mean of improving cell 
adhesion onto the surface of chitosan membranes that can be relevant in the use of 
this biopolymer in several biomedical applications. 
 
Key words: cell proliferation, fibroblasts, chitosan membranes, surface modification. 
 
3.1 INTRODUCTION 
 
The surface modification of biomaterials has been widely studied as a method for 
enhancing the performance of biomaterials, improve their multi-functionality, 
tribological, electrical, optical and mechanical properties, as well the biocompatibility 
[1]. In the case of polymeric materials, surface modification has show to be a useful 
way to obtain functional polymers by controlling their surface properties [2]. Methods 
such as adsorption, plasma techniques, grafting and chemical modification have been 
studied to perform surface treatments [1-6].  
Plasma is a mixture of electrons, negatively and positively charged particles and 
neutral atoms and molecules. Plasma is considered as being a peculiar state of matter, 
more highly activated than in the solid, liquid or gas state. From this sense, the plasma 
state is frequently called the fourth state of matter [2]. Approximately, since the 
beginning of the nineties, pulse plasmas have been used to retain the chemical 
structure of the precursor in thin film deposition for biomedical applications [7].  
Chitosan is a known natural polymer biologically renewable, biodegradable, 
biocompatible, non toxic, non-antigenic and bio-functional [8-11]. It is a linear 
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polysacharide composed of randomly distributed β-(1-4)-linked D-glucosamine 
(deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit), commercially 
produced by deacetylation of chitin [9, 12]. Chitin is a natural polymer found in many 
arthropods like shells of marine crustaceans (crab, shrimp and shellfish), insects and 
cell walls of fungi. Chitosan has been widely investigated and its has been used in 
several biomedical applications such as wound healing [6, 13-16], drug delivery [10], 
cell encapsulation [17], orthopaedic/periodontal applications [18], tissue engineering 
[9, 19] and radiopharmaceuticals [10] in a variety of forms including powders [20], gels 
[21], porous structures [22-24], fibers [25, 26], films [10], membranes [27, 28], 
capsules, particles or spheres [10, 29-31].  
Previous studies report that chitin and chitosan have intrinsic accelerating wound 
healing properties [32]. The history of chitin and its derivatives as wound healing 
accelerators began with the studies of Pruden et al 1957 and 1970 [16]. The most 
important characteristics of chitin and chitosan for their used in wound dressing tissue 
are related to haemostatic  action, biodegradability, biocompatibility, retention of 
growth factors, release of glucosamine and N-acetyl glucosamine monomers and 
oligomers, and stimulation of cellular activities [10]. Additionally, previously studies 
suggest that chitin and chitosan stimulate the migration of polymorphonuclear and 
mononuclear cells, and accelerate the reformation of connective tissue and 
angiogenesis [32]. Others studies showed that chitosan promotes the migration of the 
production and secretion of a large repertoire of pro-inflammatory products and 
growth factors, in a very early phase of healing [16].  
The results of a previous study performed by our group [33] have shown that 
surface properties such as roughness, wettability and surface chemistry on chitosan 
membranes were clearly modified through the plasma surface treatment. These 
changes on the membrane surface influenced their cellular behaviour with respect to 
non-modified chitosan. Therefore, in this study, we have analysed in more detail the 
biological response of fibroblasts seeded onto these chitosan membranes modified by 
plasma treatment performed under different conditions. 
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3.2 MATERIALS AND METHODS 
 
3.2.1 TEST MATERIALS 
The studied materials consisted of chitosan membranes obtained by solvent 
casting and submitted to plasma treatment as described previously [33]. Briefly, the 
plasma treatment was carried on a plasma reactor equipment (PlasmaPrep5, 
Germany), using a power of 20 w. The duration of the glow discharge treatment was 
varied from 10 min to 40 min, using nitrogen gas samples designated as ChtP1- ChtP4 
and argon gas samples designated as ChtP5- ChtP8 (See Table 3-1). Untreated chitosan 
membranes were used as control and designated by Cht. 
 
Table 3-1. Plasma conditions used on chitosan membranes 
Conditions/Samples ChtP1 ChtP2 ChtP3 ChtP4 ChtP5 ChtP6 ChtP7 ChtP8 
Power [watts] 20 20 20 20 20 20 20 20 
Time [min] 10 20 30 40 10 20 30 40 
Gas Nitrogen Nitrogen Nitrogen Nitrogen Argon Argon Argon Argon 
 
All the membranes submitted to plasma surface modification treatments were cut 
into squares of 1x1 cm2 and sterilized by ethylene oxide prior to all the biological 
studies performed. 
 
3.2.2 CYTOTOXICITY ASSAYS 
The cytotoxicity of leachables of all the treated membranes was evaluated using 
two cell culture methods, namely MEM extraction test (72h-short term) and MTT test, 
both carried out after 24 h extraction period, according to protocols described in 
ISO/EN 10993 [34]. Latex rubber (Dermagip, WRP) was used as a positive control and 
standard culture plates (Costar 96 well plates) were used as negative control. For this 
test, extracts of the membranes (and positive control material), were obtained by 
immersion in culture medium for 24 hours at 37 ⁰C, 60 rpm. 
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3.2.2.1 Cell culture 
A cell line of mouse lung fibroblast (L929) was selected for all the biological assays, 
obtained from European Collection of Cell Cultures (ECC, UK). This cell line was grown 
as a monolayer cultured in 75 cm2 culture flasks, using Dulbeco’s Modifed Eagle’s 
Medium-low glucose (DMEM; Sigma-Aldrich, Portugal), supplemented with 10% foetal 
bovine serum (FBS; Biochrom AG; Germany), 1 % antibiotic/antimycotic (Invitrogen, 
Portugal) and sodium bicarbonate (Sigma, Portugal) at 37 ⁰C in a 5 % CO2 incubator 
[35]. The culture medium was changed every 2 days and cells were grown until 
confluence, before starting each cytotoxicity test. For the MEM extraction test, cells 
were seeded in 6-well plate (n = 3) at a density of approximately 4.5 x 104 cell/ml. In 
the MTT test, cells were seeded in 96-well plates (n = 6), at density of approximately 
6.6 x 104 cell/ml. 
L929 mouse fibroblasts cell line was used in this study. Furthermore, in previous 
studies recognized that the fibroblasts are critical in the wound healing process [32]. It 
is currently accepted that the fibroblasts follow inflammatory cells into sites of tissue 
injury and contribute to wound healing through the synthesis of structural proteins. 
They also facilitate wound contraction and the reorganization of the extracellular 
matrix [32]. This cell line is also commonly used for cytotoxicity assessments related 
with biomaterial applications as these cells are able to maintain their phenotypic 
characteristics for long periods in culture [36]. 
 
3.2.2.2 MEM extraction test (72h) 
The MEM (Minimum Essential Medium) extract test is a cytotoxicity test that has 
as main objective evaluating qualitatively the rates of cell damage (change of cellular 
morphology, inhibition of cell growth, cellular lysis and confluence of monolayer). 
Extraction procedure: The chitosan membranes (60 samples of 1 cm2 each) and the 
positive control (latex rubber- 60 squares of 1 cm2) were immersed in 50 ml sterile 
tubes containing 10 ml of culture medium (the same used for cell culture) and placed 
in a water bath at 37 ⁰C and 60 rpm for 24 hours. After this time, the tubes were 
Chapter 3. Cell adhesion and proliferation onto 
chitosan based membranes treated by plasma surface 
modification 
Novel polymeric systems based on natural materials: 
development and biological performance 
 
78 
removed from the water bath and their content (extract material) was filtered using a 
membrane filter of 0.45 µm (Schleicher & Schuell Microscience, Germany) and 
transferred to new sterile tubes. 
Test culture and evaluation of MEM extraction test (72h). For this test, the extracts 
of the chitosan membranes treated with plasma and argon plasma were obtained by 
immersion for 24 hours as previously explained. The culture medium in each well was 
replaced by the same amount (2 ml) of extraction fluid and the response of the cells 
was evaluated after 72 h. Morphological characteristics were evaluated after 24, 48 
and 72 hours using an inverted light microscope (Zeiss, Axiovert 40 CFL, 459306), and 
compared to the negative and positive control. The observations based on the 
confluency of the monolayer, degree of floating cells and changes in cellular 
morphology were scored, according to the parameters defined in Table 3-2, and as has 
reported in previous studies carried out in our group [25, 35, 37, 38].  
 
Table 3-2. Scoring for morphological changes, confluence and cell death, used in the cytotoxicity tests 
Score 
Confluency 
[%] 
Floating cells 
[%] 
Change of cellular morphology 
Inhibition of 
cell growth [%] 
0-1 100 0 No changes during test period 0-10 
1-3 90-100 0-5 Slight changes, few cells affected 10-30 
3-5 60-90 5-10 Mild changes some cells round/spindle shaped 30-50 
5-7 30-60 10-20 Moderate changes, many cells round/spindle 50-70 
7-8 0-30 >20 
Severe changes, about all cells show morphological 
changes 
70-100 
 
 
After 72h testing, the cells were detached from the culture wells by means of 
trypsinization. The percentage of growth inhibition was determined by cell counting, 
using a Neubauer camera and scored after correction for the value of the negative 
control. Addition of these two scores results in the final cytotoxicity response index 
ranging form 0 to 8 (see scores on Table 3-3). 
 
 
Chapter 3. Cell adhesion and proliferation onto 
chitosan based membranes treated by plasma surface 
modification 
Novel polymeric systems based on natural materials: 
development and biological performance 
 
79 
 
Table 3-3. Cytotoxicity indexes used to classify the reactivity of tested samples - cytotoxic response 
Cytotoxic response Reactivity Pass/fail 
0-1 None Pass 
1-3 Slight toxic Pass 
3-5 Mild toxic Retest 
5-7 Moderate toxic Fail 
7-8 Severe toxic Fail 
 
3.2.2.3 MTT test 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-Sigma), is 
a yellow vital dye that is actively converted into blue formazan crystals by 
mitochondrial oxidation-reduction reaction [39]. The crystals formed intracellularly 
were dissolved by isopropanol [40]. In this study, MTT assay was used to assess the cell 
proliferation and cytotoxicity on the nitrogen and argon-plasma surface modification in 
chitosan membranes. 
This assay followed the same extraction and culture procedure described 
previously for the MEM test. After 72 h testing, a MTT solution was prepared (1 mg 
MTT/ ml in DMEM without red phenol and FBS) and 50 µl of this solution was added to 
the culture wells. The cultures were then incubated for 4 h at 37 ⁰C in the dark. 
Following this time, the MTT solution was removed and replaced by isopropanol (100 
µl) for 15 minutes, in order to lyse the cells (the purple solution appeared). Finally, the 
optical density (OD) was measured in a microplate reader (BIO-TEK – Synergy HT) at 
570 nm with a background correction of the OD at 650 nm [37]. The evaluation 
expresses the variation of the absorbance in function of the concentration of extracted 
material. The cytotoxicity of extracts was evaluated calculating the cell viability by 
using the following equation (adapted of Zhang et al. 2006): 
Eq. 1    Cell viability (%) = (ODs/ODcontrol)*  
Where, ODs is the optical density obtained in the samples (cells exposed to each 
extract-chitosan membrane) and ODcontrol is the optical density obtained in the 
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negative control (cells incubated with the culture medium only) [41]. The results were 
expressed as percentage of cell viability. 
 
3.2.3 DIRECT CONTACT ASSAY – ASSESSMENT OF CELL ADHESION AND 
PROLIFERATION OF L929 CELLS SEEDED ONTO CHITOSAN MEMBRANES  
The Direct Contact assay was used to evaluate the cell adhesion and cell 
proliferation on the surface of chitosan membranes modified by different argon and 
nitrogen plasma treatments. L929 fibroblast cells were initially harvested from 
monolayer cultures using trypsin-EDTA. A cell suspension was prepared in order to 
obtain a cell density 8 x 104 cells/cm2 [27]. The membranes were placed in 24 well 
plates and 100 µl of this cell suspension was seeded onto the samples surface (1x1 
cm2). Empty wells and coverslips (Sarstedt, USA), were also seeded with the same 
amount of the cell suspension to be used as controls. All the seeded samples and 
controls were incubated at 37 ⁰C in an atmosphere containing 5 % of CO2 for 2-3 hours. 
After this time, 1.5 ml of DMEM culture medium was added into each culture well and 
the samples cultured for different periods of time, namely 3, 7 and 14 days. The 
culture medium was changed every two days. 
The cell adhesion and proliferation was assessed qualitatively using light 
microscopy (after blue methylene staining), scanning electron microscope (SEM) and 
quantitatively using the MTS test. 
 
3.2.3.1 SEM analysis of the membranes 
After each culturing period, the chitosan membranes were removed from cultured 
and washed with PBS, before being dehydrated using an increased concentration 
series of ethanol solutions (25%, 30%, 50%, 70%, 80%, 90% and 100% - each 30 min). 
The membranes were then dried at room temperature and sputter coated with gold 
before observation in a scanning electron microscope (SEM-Leica Cambridge S360). 
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3.2.3.2 MTS test- cellular viability 
Cellular viability and proliferation were assessed by the MTS-CellTiter 96  
aqueous one cell proliferation assay (Promega, Madison, USA). The MTS (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
test has been described previously [42-44]. Briefly, in this test a substrate – the MTS – 
is bioreduced into a brown formazan product by dehydrogenase enzymes in 
metabolically active cells [42, 43]. In this study, MTS solution was prepared with 
DMEM without phenol red and FBS in a 5:1 ratio, where 300 l of MTS solution was 
added to membranes/cells and incubated for 3 hours at 37 ⁰C, in an atmosphere 
containing 5 % of CO2 in the dark. After this incubation period, 100 l of solution from 
each membrane was transferred to 96-well plates (in triplicate) and the absorbance 
was determined at 490 nm using a microplate reader (BIO-TEK – Synergy HT). The 
results were expressed as absorbance obtained for the samples in each culture period. 
 
3.2.4 STATISTICAL ANALYSIS 
Statistical differences in cell viability of the different samples studied were 
determined by Student’s t-test. p 0.05 was considered statistically significant. 
 
3.3 RESULTS AND DISCUSSION 
 
3.3.1 IN VITRO CYTOTOXICITY ASSESSMENT 
3.3.1.1 Cytotoxicity effect of leachables obtained from chitosan membranes treated 
by argon and nitrogen plasma on L929 cells 
Regarding the short-term MEM extraction test, the results showed that no cell 
growth inhibition occurred after 72 h of exposition to the studied membranes extracts 
(Table 3-4). Morphological observations using light inverted microscope showed that 
cells in the negative control, exhibited normal morphology and cell proliferation 
(Figure 3-1a). The oppositely effect was observed in the positive control, where the 
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cells exposed to latex extracts showed severe morphological changes and inhibition of 
cell proliferation (Figure 3-1b).  
 
Table 3-4. Growth inhibition and cytotoxic response in short-term MEM extraction test after 72h testing 
Material 
Inhibition of 
cell growth [%] 
Cytotoxic 
response 
Reactivity Pass/fail 
ChtP1 0 0.00 None Pass 
ChtP2 0 0.00 None Pass 
ChtP3 0 0.00 None Pass 
ChtP4 0 0.00 None Pass 
ChtP5 0 0.11 None Pass 
ChtP6 0 0.11 None Pass 
ChtP7 0 0.00 None Pass 
ChtP8 0 0.00 None Pass 
CHT 0 0.00 None Pass 
Latex 4 7.44 Severe Fail 
 
The extracts obtained from plasma surface modified membranes did not induce 
changes in the cell morphology and cell growth in the fibroblasts exposed to these 
extracts (Figure 3-1c to 3-1g), revealing a normal cell morphology and proliferation 
patterns, similar to those of the negative control, demonstrating the non cytotoxic 
effect of the membranes modified under different conditions. 
The results obtaining in the MTT test showed, in general, that the leachables 
obtained from all chitosan membranes surface modified by argon and nitrogen plasma, 
did not demonstrate any cytotoxic effect, confirming the results obtained in MEM 
extract test. 
However, the membranes treated with nitrogen plasma exhibited significant 
differences in terms of cell viability when compared to argon plasma treated 
membranes. In fact, the extracts obtained from chitosan membranes surface modified 
by nitrogen, the percentage of cell viability oscillated between 70 and 90% (Figure 3-2), 
while the chitosan membranes surface modified by argon showed lower cell viability, 
in special the formulations ChtP6 (20w20m-Ar) and ChtP7 (20w30m-Ar), where the 
percentage obtained varied between 40 and 45% (Figure 3-2). Nevertheless, the cells 
in contact with extracts obtained from all membranes formulations did not show 
significant morphological changes when compared with the negative control, 
Chapter 3. Cell adhesion and proliferation onto 
chitosan based membranes treated by plasma surface 
modification 
Novel polymeric systems based on natural materials: 
development and biological performance 
 
83 
demonstrating no signs of any cytotoxicity effect. These results show that these 
treatments do not affect the non-cytotoxic behaviour of the chitosan membranes. 
 
 
Figure 3-1. Morphology of L929 cells incubated with extracts of: a) negative control (DMEM culture 
medium), b) Positive control (latex extract), c) ChtP1 extract, d) ChtP5 extract, e) ChtP3 extract, f) ChtP7 
extract, g) Cht extract (untreated membrane), over a 72 h period (Photographs were taken with an 
inverted light microscope using a 20X magnification). 
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Figure 3-2. Percentage of cell viability, obtained from the MTT assay, of the fibroblast exposed to 
extracts of chitosan membranes surface modified by argon and nitrogen plasma (at different 
conditions). 
 
3.3.1.2 Effect of surface modification in chitosan membranes using argon and 
nitrogen plasma treatments in cell adhesion and proliferation 
Direct contact assay was used to evaluate the cell adhesion and proliferation on 
chitosan membranes surface modified by argon and nitrogen plasma treatments. In 
general, the SEM and optical microscopy observations performed after different 
culture periods, revealed a higher cell adhesion and proliferation of the fibroblast in 
contact with the chitosan membranes modified with argon and nitrogen plasma as 
compared to non modified membranes (Figures 3-3 and 3-4). 
The cell proliferation in all chitosan membranes modified by both treatments 
increased with culture time, while for non treated membranes this was not evident. In 
fact, surface treated membrane exhibited the formation of a cell monolayer on the 
surfaces about 70 - 80% confluent after 7 days and 80 -100% confluent after 14 days of 
culture.  
In the optical and SEM pictures (Figures 3-3 and 3-4) it is possible to observe that 
fibroblasts spread onto the surface of the membranes exhibiting a flatted morphology 
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that demonstrated a good adherence to the surface. In contrast, in untreated 
membranes, the fibroblasts exhibited round morphology, showing low cell adherence 
and proliferation (Cht). Chitosan untreated membrane did not induce neither cell 
adherence nor proliferation onto the surface with increasing culturing times. 
As mentioned before, plasma treatment offers a method of altering the surface 
characteristics of materials without afecting the material’s physical properties [45]. 
Previous studies [5, 45] showed that the surface functional groups resulting after 
plasma treatment contained high levels of oxygen and nitrogen; both groups are 
known to enhance cell adhesion [45]. In our case, chitosan surface membrane was 
modified by plasma using nitrogen and argon plasma. The literature describes [5] that 
nitrogen-containing plasma are widely used to improve wettability, printability, 
bondability and biocompatibility of polymers surfaces. Nitrogen plasma has been used 
to provide surface amino binding sites for immobilization of heparin on a variety of 
polymers surfaces [5]. Oxygen functionalities are always incorporated in nitrogen-
plasma-treated polymer surfaces. The incorporation of oxygen on polymer surfaces 
after and during non-oxygen plasma treatments is a common phenomenon. Free 
radicals that are created on a polymer surface can react with oxygen during a plasma 
treatment. Furthermore, free radicals that remain on a polymer surface after a plasma 
treatment will react with oxygen when the surface is exposed to the atmosphere [5]. 
The presence of free radicals and oxygen incorporated by nitrogen plasma in chitosan 
membranes may explain our results, which demonstrate and enhanced cell spread and 
proliferation after plasma treatments in chitosan membranes (Figure 3-3). 
Figure 3-4, shows the fibroblasts cells attachment to chitosan membranes 
modified by argon plasma, where the cellular response was similar to that observed in 
nitrogen treated membranes. Argon plasma is known for producing bond breaking and 
introducing oxygen groups on the surface materials [40]; these groups can be 
important in the cell attachment and cell growth because the presence of oxygen-
containing functional groups such as carboxyl can increase acidity of the surface. On 
the other hand, ester, carbonate and hydroxyl groups can increase the basicity of the 
surface [40]. The acidic and basic groups could be enhancing the interaction of the 
chitosan membranes with the basic and acid amino acids of serum protein such as 
fibronetic and vitronectin [40, 46]. 
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Figure 3-3. SEM (left) and optical micrographs after blue methylene staining (right-10X) of L929 
fibroblasts cultured on untreated chitosan membranes (control) and chitosan membranes modified by 
nitrogen plasma (using different conditions) after 7 days of culture: A1-A2: Cht (untreated chitosan 
membranes); B1-B2: ChtP1; C1-C2: ChtP2, D1-D2: ChtP3; E1-E2: ChtP4. 
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Figure 3-4. SEM (left) and optical micrographs after blue methylene staining (right-10X) of L929 
fibroblasts cultured on untreated chitosan membranes (control) and chitosan membranes modified by 
argon plasma (using different conditions) after 7 days of culture: A1-A2: Cht (untreated chitosan 
membranes); B1-B2: ChtP5; C1-C2: ChtP6, D1-D2: ChtP7; E1-E2: ChtP8.  
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Additionally, previous studies using different plasma treatments containing high 
levels of oxygen and nitrogen groups exhibited same behaviour, i.e., enhanced cell 
adhesion was obtained [4, 40, 45], demonstrated that plasma is an efficient treatment 
to improve the biological response on surfaces at materials such as chitosan based 
membranes. Indeed, in this study, the incorporation of possible oxygen groups and 
free radicals onto chitosan membranes surface by means of argon and nitrogen plasma 
enabled high cell proliferation and cell attachment in a short period (a few days) of 
culture (more details about the surface modifications onto plasma-chitosan 
membranes can be found elsewhere [33]). In contrast, untreated chitosan membranes 
showed not to be favourable for cell attachment and proliferation like it has been 
reported in previous studies [47], probably as result of the monopolar basic nature of 
chitosan, which does not interact well with the bipolar extracellular matrix proteins 
present in the bovine serum proteins of the culture medium [40]. Moreover, the 
roughness modification in the chitosan membranes surface obtained after plasma 
treatment [33] may additionally contribute for a better adhesion of fibroblasts on 
these surface. 
The results obtained in the MTS test (Figure 3-5) suggested that, in general, 
nitrogen membranes showed a higher cell proliferation as compared with argon 
treated membranes. Nevertheless, both treatments demonstrated enhanced cell 
proliferation and viability, as compared to non-treated chitosan membranes, which 
exhibited low cell proliferation, in accordance with the SEM observations. 
The results obtained also demonstrated that the plasma conditions correspondent 
to ChtP2 and ChtP6 produced the best cell proliferation for all the culture periods 
studied. These results indicate that low power and short time conditions of exposure 
to nitrogen or argon plasma is enough to produce improvement in the cell growth on 
chitosan based membranes, where was possible to find cells with extended filipodia 
that have begun to spread on the chitosan surface membrane after 3 days of culture.  
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Figure 3-5. Cell viability and proliferation results obtained using the MTS test. Cell density used was 8 x 
104 cells/cm2. For the control, the same amount of cells was seeded on 24 culture well plates. Cells were 
kept in culture for 3, 7 and 14 days. A) Optical density (OD) obtained in chitosan membranes treated by 
nitrogen plasma, B) OD obtained in chitosan membranes treated by argon plasma. 
Asterisk (*) indicates that the cell viability onto chitosan membranes treated by argon and nitrogen 
plasma was significantly higher (p<0.05) than the untreated chitosan membranes after 7 and 14 days of 
culture. 
A 
B 
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3.4 CONCLUSIONS  
 
The surface modification of chitosan membranes with nitrogen and argon plasma 
were found to promote the proliferation of L929 fibroblasts compared to untreated 
chitosan membrane, where no cell adherence was observed. Cytotoxic assays showed 
that none of the treatments (under all studied conditions) induced any cytotoxic 
effect.  
SEM and optical microscope observations showed a clear enhancement of cell 
attachment and proliferation using argon and nitrogen plasma modified membranes as 
compared to untreated chitosan membranes. In fact, after short culturing periods, 
argon and nitrogen plasma treatment seems to produce better results in terms of cells 
attachment and proliferation. The data obtained from the MTS test confirmed those 
results, where again, it was demonstrated that nitrogen and argon plasma treatment 
performed under optimized conditions, seems to be a suitable technique for modifying 
surface properties, enhancing the biological response of chitosan membranes. High 
levels of oxygen and nitrogen obtained after plasma treatment raise the rates of cell 
proliferation in comparison with untreated membranes. 
In general, the present results showed that surface modification by plasma to be 
useful technique to treat chitosan-based material leading to enhanced cell adhesion 
and proliferation. These findings may be relevant in the development of chitosan-
based biomaterials, including in tissue engineering applications. 
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Abstract 
Microencapsulated cells in biocompatible and semi-permeable polymeric 
membranes have shown to provide an effective system to deliver cells into a 
tissue/organ while protecting the host against immune response. In this work novel 
cell encapsulation systems were developed, based on two different natural origin 
polymers, carrageenan and alginate. Additionally, two different forms of carrageenan 
were studied, namely iota- and kappa-carrageenan, both polyanions. Chitosan was 
used as a polycation for the formation of the microcapsules’ membranes. 
Furthermore, it was also studied the formation of carrageenan and alginate based 
microcapsules, based on an ionotropic gelation method using a sodium alginate and 
iota-carrageenan mixture extruded into an CaCl2-NaCl solution. Again, chitosan was 
used as a polycation to coat the formed capsules. In this case, different ratios of the 
polymers and diferent pH of the chitosan solution (adjusted by ading of β-
glycerophosphate) were studied in order to determine the best formulation/conditions 
                                                      
2 The present chapter is based on the following paper: S.M. Luna, J.V. Araujo, M.E. Gomes, N.M. Neves, J.F. Mano, R.L. Reis. 
“Development of a novel cel encapsulation system based on natural origin polymers for tisue enginering aplications” 
Submitted to Tissue Engineering, 2007.  
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to obtain the microcapsules. In addition, iota-carrageenan + sodium alginate capsules 
were also submitted (or not) to a sodium citrate treatment to analyse the differences 
between liquefied and non-liquefied capsules. All the developed capsules were 
characterized with respect to their morphology, mechanical stability and cytotoxicity. 
In general, it was possible to obtain microcapsules with a spherical shape from all the 
polymeric systems used. However, the iota-carrageenan + sodium alginate 
microcapsules exhibited the best stability and permeability, and therefore were 
selected for further studies, namely for preliminary cell encapsulation experiments. 
The obtained results also showed that the capsules produced with 30% alginate and 
70% iota-carrageenan and a chitosan solution at pH 5.0, showed better results as 
compared to capsules obtained using other polymer ratios/conditions. Cell 
encapsulation was performed using a L929-fibroblats cell line and the iota-carrageenan 
+ alginate formulation. The capsules exhibited an adequate environment for cell 
survival, demonstrating the high potential of the developed system for application in 
tissue engineering and in other cell-based therapies.  
 
Key words: capsules, carrageenan, alginate, fibroblasts, cell viability. 
 
4.1 INTRODUCTION  
 
Encapsulation has proven to be an effective method of immunoprotecting cells or 
proteins for implantation into unmatched recipients allowing simultaneously for their 
delivery via non-invasive procedures, as capsules can be injected into a target tissue 
defect. In this way, cell encapsulation is a high potential approach to treat a wide 
range of diseases [1]. Several encapsulating techniques have been developed, which 
can be generally classified as micro and macroencapsulation. Microencapsulation 
involves a smaller cell mass or a single islet entrapped in a spherical capsule. In 
contrast, macroencapsulation involves large groups of cells developed in tube or disc 
shaped hallow devices [2, 3]. 
Previous studies have been demonstrated that the polymers and the procedure to 
develop capsules are very important for the development of successful encapsulation 
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systems for tissue engineering applications [4]. For this reason, several polymers have 
been studied for microcapsule formation, such as agarose, alginate, polyacrylates, poly 
(vinyl alcohol), chitosan and poly-L-lysine [5, 6], with the objective of enhancing and 
optimising the cell immobilization by maintaining the general cell functions and 
survival rates [7, 8]. In the capsules development, it is very important to obtain 
biocompatible and semi-permeable polymeric membranes to allow for the transport of 
molecules essential for cell survival within the capsules [3]. The idea of using ultrathin 
polymer membrane microcapsules was proposed by Chang [9] in 1964 for the 
immunoprotection of transplanted cells. Nearly two decades later, the concept of 
bioencapsulation has shown to successfully maintain glucose homeostasis in rats with 
diabetes using encapsulated allogenic islets [3].  
The present study describes the development of microcapsules based on the 
combination of two natural origin polymers, namely iota-carrageenan and sodium 
alginate (both polyanions), as alternative systems for encapsulation of living cells. 
Moreover, chitosan, a well known polycation, was used for the formation of the 
capsule’s membrane. 
Carrageenan is a linear, highly flexible heteropolysaccharide with ester sulphate 
groups which curl, forming helical structures, with the ability to form a variety of 
different gels at room temperature [10]. Their main chain consists of alternating 
copolymers of 1,4-β and 1,3- -D-galactopyranose and 3,6-anhydro-D-galactopyranose. 
This polysaccharide is extracted from red seaweed (Rhodophyceace) and exists in 
three major forms designated by the Greek letters: κ (kappa), i (iota) and λ (lambda). 
The main structural difference among these different forms of carrageenans is in the 
degree of substitution of the sulphate group [10, 11]. In the case of iota and kappa 
carrageenan, the chemical structure of iota-carrageenan differs from that of kappa-
carrageenan by the presence of an additional sulphate group in the 3,6-
anhydrogalactosyl residue, which confers a more hydrophilic character to the molecule 
[12, 13]. The differences in the textural properties of iota- and kappa carrageenan gels 
reflect the differences in their structures: iota carrageenan gels consist of double 
helices with little or no aggregation, which renders them flexible and soft. In contrast, 
kappa-carrageenan gels consists of aggregated helices, where the gel formed is 
relatively brittle and hard [13, 14].  
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Carrageenans are widely used in the food and other industries (cosmetic 
products), as thickening and stabilizing agents [15]. Other studies have also 
demonstrated the benefits of carrageenans in health applications, and considered this 
polymer to be a useful microbicide that inhibits the human immunodeficiency virus 
(HIV-1) infection of epithelial at nanomolar concentrations [16]. The microbicide 
behaviour was supported by recent studies, where it was demonstrated that 
carrageenans are potent inhibitor of the infectivity of genital by human papilloma virus 
(HPV) and pseudovirus (PsV) in vitro [17]. However, the use of carrageenans as 
polymers in the encapsulation field is reduced. Previous investigations have reported 
the development of capsules using carrageenan and oligochitosan polymer [10], but 
regarding cell encapsulation the existing studies only reported the use of carrageenan 
(in special k-carrageenan) for the encapsulation of microbial cells [18-20].  
Alginate, on the contrary is the most commonly employed polysaccharide for cell 
encapsulation. It is composed of mannuronic (M) and guluronic (G) acids [21], 
extracted mainly from brown marine algae (Phaeophyceae) and as extracellular 
mucilages secreted by certain species of bacteria (Azobacter Vinelandii) [22, 23]. This 
polymer allows to develop a simple and rapid gelation with divalent metal ions such as 
Ca2+, through binding of consecutives blocks of G-molecules on individual or different 
molecules [2, 24, 25]. Therefore, many researchers used alginate as the matrix to 
prepare microcapsules to be used as an injectable cell delivery vehicle and cell 
immobilization matrix [7], involving different cell sources such as myoblasts [21, 26], 
epithelial cells [26] hybridoma cells [27, 28], fibroblasts [29, 30], pancreatic islets [3, 
30] and microbial cells [31, 32]. Additionally, alginate is relatively biocompatible and 
approved by the food and drug Administration (FDA) for human use as wound dressing 
material [33]. Nevertheless, capsules based on alginate present usually a poor 
mechanical stability [24, 34, 35]; furthermore, they require a further treatment with 
citrate to liquefied the core of the capsules and therefore enable cell survival, which 
further contributes to this low stability [21, 36]. 
Chitosan is a linear polysacharide composed of randomly distributed β-(1-4)-
linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated 
unit), commercially produced by deacetylation of chitin [37]. Chitin is a natural 
polymer found in many arthropods as shells of marine crustaceans (crab, shrimp and 
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shellfish), insects and cell walls of fungi and is used to produce a variety of forms 
including powders, gels, porous structures, fibres, membranes and films for biomedical 
applications [38-42]. Furthermore chitosan formulations allow a wide range of 
molecules to be attached, enabling its use for the delivery of growing factors [38, 43]. 
The main aim of this work was to combine advantageous features of alginate as a 
polymer for microcapsules formation with those of carrageenan, selecting chitosan as 
an appropriate polymer for the capsules membranes. In fact, chitosan is a polymer 
with positive charges it can interact with alginate and carrageenan, two anionics 
polymers, to create a membrane at the capsules surface [44], which could improve the 
mechanical stability of the structures. 
This work focuses on the development of novel microcapsule for cell encapsulation 
systems based on two methods: polyelectrolyte complex and ionotropic gelation 
methods. For the first case, iota or kappa-carrageenan were used as the polyanion 
component, forming the capsule core, that was stabilized through complexation with 
chitosan in the surface. In the case of ionotropic gelation a mixture of iota-carrageenan 
and sodium alginate were used to obtain the capsule core by ionic cross-linking with 
Ca2+; chitosan was used again to form the capsule membrane. In this work, iota-
carrageenan was chosen as the main polymer for ionotropic gelation method for core 
microcapsule due to the properties of the gels that are formed, being typically soft and 
elastic [10, 12-14].  
The obtained microcapsules were characterized with respect to their morphology 
by light microscopy. Mechanical stability tests allowed to select the best 
formulations/conditions to obtain the microcapsules used in cell encapsulation 
experiments. The L929-fibroblasts cell line was used as a model cell type for 
encapsulation studies. The cell encapsulation was performed in solid and liquefied 
capsules developed with alginate + iota-carrageenan mixture by ionotropic gelation 
method. 
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4.2 MATERIALS AND METHODS 
4.2.1 MICROCAPSULES DEVELOPMENT 
4.2.1.1 Materials used 
Iota-carrageenan (22045), kappa-caragenan (2048), sodium alginate (71238), β-
glycerophosphate disodium salt (β-GP/G9891), Phosphate Buffer Saline (PBS-P4417), 
sodium citrate (S1804) and DAPI (4,6-diamidino-2-phenylindole/D9564) were 
purchased from Sigma (Portugal). Low molecular weight chitosan powder was 
obtained from Aldrich/448869 (Portugal). Calcein-AM (acetoxymethyl ester of calcein) 
was purchased from Invitrogen/C3099 (Portugal). 
 
4.2.1.2 Adjustment of the pH of the chitosan solution using β-glycerophosphate 
In this study, chitosan solutions, with different pHs were used in order to form 
different types of capsules by polyelectrolyte complex and ionotropic gelation method 
[4]. It is well known that the changes in the pH produce alterations in the protonation 
degree and bonding interactions in chitosan [45]. In both methodologies used for the 
development of microcapsules, chitosan solution was used as polycation to obtain the 
membrane of the capsule at two different pHs: pH 5.0 and pH 6.0. 
Previous studies have demonstrated that chitosan can be neutralised up to 
physiological pH (7.2) using β-glycerophosphate (β-GP), without promoting the 
precipitation of the polysaccharide, which revealed to be a proper buffer [23, 45]. In 
our case, a highly diluted chitosan solution was used, preventing the formation of a 
thermogel. A curve of the variation of the pH in chitosan solution as function of β-GP 
concentration was drawn to determine the corect amount of β-GP to be added to 
reach the desired pH. For this purpose, a solution containing 0.0266 g/ml of β-GP was 
slowly added to a chitosan solution (0.30 % in 0.017 M HCl) until physiological pH. At 
this point (pH = 7), it was observed precipitation. The obtained curve is presented in 
Figure 4-1. From the curve it is evident that low concentration of β-GP is enough to 
reach the pHs used in this study (5.0 and 6.0). 
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Figure 4-1. Variation of the pH relative to amount of β-GP with respect to chitosan (weight β-GP/weight 
chitosan g/g), at room temperature 
 
4.2.1.3 Development of microcapsules based on iota and kappa-carrageenan 
Capsules were obtained using chitosan solutions at two different pHs (5.0 and 6.0) 
previously adjusted with β-Glycerophosphate (β-GP) [23], as described in previous 
section. The microcapsules based on iota and kappa-carrageenan were developed 
from a pair of oppositely charged polysaccharides. For this purpose, 1 ml of an 1.5 % 
aqueous solution of iota (or kappa)-carrageenan was added drop by drop through a 
0.3 mm needle (BD-Microfine U-100 insulin, Portugal), using a syringe pump (AL-1000, 
Aladdin Programmable Syringe Pump) into 20 ml of an 0.15 % chitosan in a solution at 
0.0085 M HCl. 
The resulting capsules were allowed to harden for 45 min at 37 ⁰C in a water bath, 
washed with 0.9 % NaCl [32, 33] and immersed in a 0.05 % iota-carrageenan solution 
for 5 minutes in order to link the remaining residues of chitosan. Finally, the capsules 
were rinsed twice with PBS and stored at 4 ⁰C in the same buffer. 
 
4.2.1.4 Development of sodium alginate + iota- carrageenan microcapsules 
Microcapsules based on iota-carrageenan (i-carrageenan) and alginate were 
developed by an ionotropic gelation method that was originally developed for the 
preparation of alginate capsules [46]. The procedure starts with the preparation of an 
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aqueous alginate/i-carrageenan mixture composed of an 1.5 % aqueous solution of 
each polymer, at two different ratios, namely 50/50 and 30/70 (v/v), in order to 
determine the best formulation. Then, 1 ml of this mixture was extruded through the 
0.3 mm needle, using a syringe pump, into 20 ml of a solution composed of 0.05 M 
CaCl2 and 0.2 M NaCl. All solutions were prepared in distilled water. The resulting 
microcapsules were allowed to harden for 30 min at 37 ⁰C. Afterwards, the capsules 
were immersed in 20 ml of chitosan solutions (pH 5.0 and 6.0) prepared as described 
before for 20 min at 37 ⁰C. Then, the capsules were rinsed with PBS for 1 min and 
immersed in a 0.05% iota-carrageenan for 5 minutes. Microcapsules with 
liquefied/depolymerised core were also prepared using a sodium citrate (a calcium 
sequestering agent) treatment. This treatment consisted in the immersion of the 
obtained iota- carrageenan + alginate microcapsules in a 0.055 M solution of sodium 
citrate for 1 min [7, 26]. Different times of immersion in the sodium citrate solution 
were used, but it was found that higher immersion times (2 or 1.5 minutes) resulted in 
the degradation and disintegration of liquefied capsules. Therefore, 1 minute was 
chosen to avoid considerable modifications in the membrane roughness in comparison 
with solid capsules. Finally, the obtained capsules (solid and liquefied) were rinsed 
twice with PBS buffer and stored at 4 ⁰C in the same buffer for posterior 
characterization. The capsules were immersed in DMEM to assess the stability of the 
microcapsules in culture medium and also to observe the permeability into the 
capsules. 
4.2.2 MORPHOLOGICAL CHARACTERIZATION OF THE DEVELOPED MICROCAPSULES  
The size and shape of the obtained microcapsules were examined under a 
stereomicroscope (Zeiss – Stemi 2000-C KL 1500 LCD, 459315) and with an inverted 
light microscope (Zeiss, Axiovert 40 CFL, 459306). The capsules were stained in 0.1 % 
(w/v) eosin dye (eosin Y solution, alcoholic with phloxine B 0.1% (w/v)/HT110316, 
Sigma-Aldrich, Portugal) to observe the membranes. The eosin dye was selected due to 
its anionic character and ability of specific binding to the amino groups of chitosan 
[47]. 
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4.2.3 EVALUATION OF MECHANICAL STABILITY 
Both solid and partially liquefied microcapsules produced using a sodium alginate 
and iota-carrageenan mixture and a chitosan solution at pH 5.0, were submitted to a 
short-term stability evaluation assay, in order to select the capsules presenting the 
best stability properties for the cell encapsulation experiments. The mechanical 
stability assay procedure was similar to the described by G. Orive et al, 2001. Briefly, 
50 capsules of each type were placed in 24-well-plate (10 per well) with 800 µl of 
phosphate buffer saline solution (PBS-Sigma, Portugal) in each well. The culture plate 
was then agitated at 200 rpm and 25 ⁰C for different periods of time, namely 1, 3, 6, 24 
and 48 hours. The capsules that ruptured were counted under a stereomicroscope. 
Results are presented as the percentage of rupture capsules as a function of time. 
 
4.2.4 ASSESSMENT IN VITRO CYTOTOXICITY OF THE DEVELOPED CAPSULES 
In order to evaluate the possible toxic effects of leachables from the developed 
microcapsules and polyanions used, it was used the MTT Test. Latex rubber (Dermagip, 
WRP) was used as a positive control and standard culture plates (Costar 96 well plates) 
were used as a negative control. For this test, extracts of the capsules (and positive 
control), were obtained by immersion in culture medium for 24 hours at 37 ⁰C and 60 
rpm in a thermostatic bath. 
 
4.2.4.1 Cell culture 
A mouse lung fibroblast cell line (L929) obtained from European Collection of Cell 
Cultures (ECC, UK) was selected for the cytotoxicity assays. Fibroblasts are commonly 
used for cytotoxicity assessments related to biomaterial applications, as they are able 
to maintain their phenotypic characteristics for long periods in culture [48-52]. 
Cells were grown as monolayer in 75 cm2 culture flasks, using Dulbeco’s Modifed 
Eagle’s Medium-low glucose (DMEM-Sigma-Aldrich, Portugal), supplemented with 10% 
Foetal Bovine Serum (FBS, Invitrogen, Portugal), 1% antibiotic/antimycotic (Invitrogen, 
Portugal) and sodium bicarbonate (Sigma,  Portugal) at 37 ⁰C in a 5 % CO2 incubator. 
Cells were harvested before reaching confluence from 75 cm2 culture flasks using 
trypsin-EDTA (Invitrogen, Portugal) and cell suspension was prepared in order to 
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obtain a cell density of 6.6 x 104 cell/ml. Cell suspension (200 µl/well) was cultured in a 
96-wel culture plates in Dulbeco’s Modifed Eagle’s Medium (DMEM). After the cels 
were attached to the culture plate, the culture medium was replaced by 150 µl of 
extracted capsules prepared in complete culture medium and incubated for 24, 48 and 
72 h at 37 ⁰C. 
 
4.2.4.2 Preparation of the extracts 
The extracts were obtained by immersion of 100 microcapsules (of each type) in a 
sterile tube containing 5 ml of DMEM and placed in a water bath at 37 ⁰C and 60 rpm 
for 24 hours. After this time, the extract was filtered using a 0.45 µm syringe filter 
(Schleicher & Schuell Microscience, Germany). In the case of the positive control 
material, 60 squares of 1 cm2 aproximately of latex rubber were immersed in DMEM 
culture medium following the same procedure described above for the test materials. 
 
4.2.4.3 MTT test 
This colorimetric assay is based on the ability of mitochondrial dehydrogenasa 
enzymes of living cells to convert 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide (MTT, Sigma) into an insoluble formazan [53]. In this assay, 50 µl of the MTT 
solution (1 mg MTT/ml DMEM without phenol red) was added to the cell monolayer, 
previously exposed to extracts obtained from the capsules, and incubated at 37 ⁰C in a 
5% CO2 incubator for 4 hours. Afterwards, the MTT solution was removed and replaced 
by 100 µl of isopropanol in order to lyse the cells [54]. The solution became purple and 
the optical density (OD) was measure in a microplate reader (BIO-TEK – Synergy HT) at 
570 nm, with a background correction of the OD at 650 nm. The evaluation expresses 
the variation of the absorbance in function of the concentration of extracted material 
[36, 55]. The cytotoxicity of extracts was evaluated, calculating the cell viability by 
using the following equation: 
 
Eq. 4-1.                      Cell viability (%) = (ODsample/ODcontrol)*100 
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Where, ODsample is the optical density obtained in the cells exposed to each 
extract/capsules and ODcontrol is the optical density obtained in the cells incubated with 
the culture medium only (negative control) [56]. The results were expressed as 
percentage of cell viability.  
 
4.2.5 CELL ENCAPSULATION  
Immobilisation of the cells was performed using a L929 fibroblasts cell line in 
sodium alginate + iota-carrageenan capsules (solid and liquefied beads). Microcapsules 
and cell encapsulation procedures were carried out at room temperature under sterile 
conditions, using a laminar flow cabinet. All solutions were prepared in distilled water 
and filtered using a membrane filter of 0.2 µm (Schleicher & Schuell Microscience, 
Germany). The sodium alginate, iota-carrageenan and chitosan solutions were 
autoclaved prior to these experiments. The fibroblasts cells were initially harvested 
from monolayer using trypsin-EDTA (Invitrogen, Portugal), and a cell suspension 
containing a know amount of cells was prepared. The cells (5x103 cells per ml of the 
polymeric solution) were then mixed with the sodium alginate + iota-carrageenan 
solution (30/70). The cells-polymeric solution suspension was extruded into a calcium 
chloride-sodium chloride (CaCl2-NaCl) solution, as described above using a syringe 
pump. The resulting microcapsules/cells were maintained in CaCl2-NaCl for 30 min at 
37 ⁰C in a 5 % CO2 incubator. Afterwards, the capsules containing the cells were 
immersed in 20 ml of chitosan solution (adjusted to pH 5.0 with β-GP) for 10 min and 
at 37 ⁰C in a 5 % CO2 incubator. After this, the capsules were rinsed with PBS for 1 min 
and immersed in 0.05% iota-carrageenan for 5 minutes. To obtain the liquefied 
capsules, the microcapsules with cells were treated with 0.055 M of sodium citrate for 
1 minute. Finally, microcapsules with cells were washed twice with PBS, transferred to 
several wells of a 6-well culture plate, and immersed in culture medium. The 
encapsulated cells were cultured in a 5 % CO2 incubator for different periods of time, 
namely 1, 2, 3 and 7 days. The culture medium was carefully changed every 2 days. 
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4.2.6 MORPHOLOGICAL CHARACTERIZATION IN ENCAPSULATED CELLS  
The size and shape of the microcapsules containing the cells was analyzed using a 
stereomicroscope. The morphology of the cells, as well as the possible formation of 
cell aggregates was analyzed using an inverted light microscope (Zeiss, Axiovert 40 CFL, 
459306). Additionally, viability of the cells was also assessed using the methylene blue 
stain. 
 
4.2.7 ASSESSMENT OF THE VIABILITY OF ENCAPSULATED CELLS 
4.2.7.1 MTS assay 
Cellular viability of entrapped fibroblasts cells was determined using the MTS (3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) test [55, 57]. In this study, the microcapsules (30/70) containing cells (3 
capsules per well) were immersed in culture medium containing MTS, in a 5:1 ratio, 
and incubated at 37 ⁰C. After 3 hours of incubation, 10 µl of the solution obtained 
from each well (containing the encapsulated cells) were transferred to 96-well plates. 
The absorbance was read in a microplate reader (BIO-TEK – Synergy HT) at 490 nm. 
The results were expressed as absorbance obtained for samples corresponding to each 
culture period. As a control, was used the solution performed with alginate + iota 
carrageenan mixture (30/70) + fibroblasts cells. 
 
4.2.7.2 Calcein-AM and DAPI fluorescents staining 
Two fluorescent dyes were used to assess the cellular viability in encapsulated 
cells: Calcein-AM (acetoxymethyl ester of calcein, Invitrogen), is a green dye which 
identifies viable cells [58]; DAPI (4,6-diamidino-2-phenylindole, Sigma), is a blue dye 
which identifies cell nucleus in live and fixed cells [59]. In this assay, the capsules were 
placed in to an eppendorf tube containing 1 ml of DMEM and 2 µl of Calcein-AM and 
incubated for 20 min at 37 ⁰C in a 5 % CO2 incubator. Afterwards, the capsules were 
rinsed in DMEM culture medium and PBS solution. The PBS was replaced by 500 µl of 
glutaraldehyde (2.5%) for 10 min at room temperature to fix the cells. Then, the 
glutaraldehyde was removed and the capsules were rinsed twice in PBS. New PBS 
solution (1 ml) and 2 µl of DAPI was added for 20 min at 37 ⁰C in a 5% CO2 incubator.  
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Finally, the capsules were rinsed twice in PBS and observed under a fluorescence 
microscope (Zeiss 434301) using Alexa Flour 488 and DAPI 49 (Molecular Probes). All 
the procedure was performed in the dark. 
 
4.2.8 STATISTICAL ANALYSIS 
The results obtained in the mechanical stability tests and in the MTT (in vitro 
cytotoxicity of capsules leachables) and MTS tests (as cellular viability of encapsulated 
cells) are presented as means ± standard deviations. Statistical analysis of the results 
was performed using the Student’s t-test, with a significance level of 95 % (p < 0.05). 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 PREPARATION OF THE MICROCAPSULES 
4.3.1.1 Development of microcapsules based on iota and kappa-carrageenan 
The results showed that were possible to produce capsules using iota or kappa-
carrageenan via complexation with low molecular weight chitosan. Observations using 
a stereomicroscope and inverted light microscope revealed that kappa and iota-
carrageenans used in this study formed approximately spherical shape microcapsules 
with a diameter in the range 2.0-2.2 mm (Figure 4-2). It is well known that both 
carrageenans have polyelectrolytic character and form a thermoreversible gel which is 
induced by selected monovalent and/or divalent metal cations [10, 13]. 
The pH of the chitosan solution used during the capsules formation influenced the 
capsule structure. The capsules formed at low pH (5.0), exhibited a smoother surface 
than the capsules formed at pH 6.0. This is probably due to the fact that, at pH 5.0, the 
capsules have the high degree of protonation of the chitosan that can induce a more 
homogeneous complexation. These results are in accordance with 
alginate/oligochitosan and carrageenan/oligochitosan systems developed in other 
studies, where a more compact polyelectrolyte complex with higher crosslinking 
density was formed [10, 35, 47]. 
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Figure 4-2. Optical microscopy images taken at pH 5.0 of the obtained microcapsules based on A1-A3) 
kappa-carrageenan and B1-B3) iota-carrageenan. 
 
Previous studies have demonstrated that the thickness and strength of the capsule 
wall can be controlled, to some extent, by varying the molecular weight of the 
constituent polymers. Lower molecular weight forms diffuse through the capsule 
membrane more rapidly and thus produce thicker walls before being hampered by the 
diffusion distance. For instance, lower molecular weight chitosan produce capsule 
walls that are both thicker and less elastic than those made with higher molecular 
weight forms [4, 60, 61]. As a result, the highly diluted chitosan solution and its low 
concentration (0.15 %) using in the capsules developed can produce a membrane with 
less elasticity but with fewer incidences of physical defects. Moreover, the low Mw 
chitosan, used in this assay can increase its capacity to penetrate and interact with the 
core polymer [4].  
In general, k-carrageenan generated thicker gels in the core as compared to i-
carrageenan (Figure 4-2). We expect then that microcapsules based on k-carrageenan 
will prevent the exchange of gases and nutrients, harming the viability of the 
encapsulated cells. Therefore, iota-carrageenan was selected for further studies, 
concerning the development of microcapsules based on the combination of this 
polymer with alginate. Previous studies [35] have demonstrated that iota-carrageenan 
and alginate are similar because both polymers have one anionic group per glucosic 
unit, producing a more compact and resistant capsule in comparison with kappa-
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carrageenan which has a lower degree of substitution (one anionic group per two 
glucosic unit). 
 
4.3.1.2 Development of sodium alginate + iota-carrageenan microcapsules 
The capsules based on alginate and iota-carrageenan were produced from a 
mixture of two “strong” polyanions extruded into a geling agent (CaCl2) and antigelling 
(NaCl) [62]. According to optical microscope observations, the capsules performed 
exhibited spherical shape, thin and smooth surface and revealed good stability in PBS 
and in culture medium (See Figure 4-3). The diameter of the solid capsules (non-
liquefied) was about 2.0 mm, while the liquefied capsules exhibited average diameters 
of 2.3 mm. The increase in diameter in liquefied capsules can be explained by the 
citrate treatment, that can enhance the swelling of the capsules [28, 36]. The citrate, a 
sequestering agent, generates a strong bound between calcium ions and non-gelling 
sodium or potassium ions. The decrease of the Ca2+ bound between the alginate chains 
increase the swelling pressure inside the capsule, modifying the original diameter [1, 
34]. 
On the other hand, the capsules obtained with different iota-carrageenan and 
alginate ratios and different pHs showed similar size, shape and stability in PBS and 
culture medium. However, the capsules obtained at pH 5.0 exhibited a smoother 
membrane and better handling properties in comparison with capsules obtained at pH 
6.0. In fact, previous studies have demonstrated that the pH of a solution is a handy 
tool for modulating polyelectrolyte membranes [4]. For instance, the cationic polymer 
chitosan is soluble at low pH, but its solubility decreases as alkaline pH is approached. 
Moreover, the micropores of chitosan membrane capsule assume minimum 
dimensions at low pH, but at about pH 6.0 and higher, repulsive forces produce the 
pores to open up, and consequently, membrane permeation rise [4]. 
Previous studies [62] concluded that NaCl is one of the factors determining 
membrane permeability as well as surface topology. Sodium ions control the initial 
stage of complex formation. The negative charges of the reacting polymers suppress 
the reaction of calcium ions with the polyanion matrix. Therefore, by increasing the 
ratio of Na+ to Ca2+ for a given polyanion mixture, it is possible to obtain a wrinkle-free 
surface [4]. 
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Figure 4-3. Optical microscopy images of solid capsules obtained using different polymer ratios and at 
different pH of the chitosan solution: A1-A2) microcapsules obtained from a mixture of sodium 
alginate/iota-carrageenan (30/70) at pH5; B1-B2) microcapsules obtained from a mixture of sodium 
alginate/iota-carrageenan (30/70) at pH6; C1-C2) microcapsules obtained from a mixture of sodium 
alginate/iota-carrageenan (50/50) at pH5; D1-D2) microcapsules obtained from a mixture of sodium 
alginate/iota-carrageenan (50/50), at pH6. The microcapsules (A, B, D) were dyed with eosin for a better 
observation of the chitosan membrane. 
 
4.3.2 ASSESSMENT OF MECHANICAL STABILITY 
The mechanical stability of microcapsules is one of the major concerns in the 
design of cell immobilisation devices for therapeutic purpose where it is necessary a 
good mechanical stability in order to prolong their long-term in vivo function [63]. In 
this study, a stability assay was performed to analyse four types of the capsules 
developed: solid capsules 30/70 (SA-IC sodium alginate + iota-carrageenan), liquefied 
capsules 30/70 SA-IC, solid capsules 50/50 SA-IC and liquefied capsules 50/50 SA-IC. 
The results obtained by the short-term stability showed a similar percentage of 
ruptured capsules for all the studied systems (Figure 4-4). Notwithstanding, capsules 
produced using a mixture 50/50 SA-IC of the polymers exhibited lower stability in the 
mechanical study (± 10 % more of ruptured capsules) as compared to capsules formed 
using 30/70 SA-IC polymers. These results might be explained by the increase in the 
iota-carrageenan content of this formulation as the higher amount of ionic sulphate 
groups that repel each other, contribute for maintaining the molecules highly 
extended. Furthermore, the gradual substitution of alginate, a rigid polymer, by 
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carrageenan, an extremely flexible polymer provides the flexibility required to adapt to 
the varying stress of tidal and wave motion caused by the agitation [25, 64]. 
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Figure 4-4. Percentage of ruptured microcapsules (correspondent to different sodium alginate/iota-
carrageenan ratios) as a function of time. 
 
Figure 4-4 shows the percentage of ruptured capsules. In the first six hours, 
liquefied and solid (non-liquefied) 50/50 SA-IC capsules, presented a similar behaviour. 
However, for 30/70 SA-IC composition, solid capsules presented a higher mechanical 
stability for that same time period. This suggests that the decreasing stability is caused 
by the swelling effect related to the treatment with sodium citrate, which affects more 
the capsules with higher concentration of alginate. After 24 h, both 30/70 and 50/50 
non-liquefied capsules present an increase in the percentage of rupture that can be 
related to the mass transfer (in our case is related with the PBS solution transfer 
through of capsule membrane), which from this period may develop an important role 
on capsules stability. As it is well known, the mass transfer is increased in liquefied 
capsules, and the equilibrium is reached faster than in non-liquefied ones. 
Nevertheless, before reaching the equilibrium, the mass transfer in non-liquefied 
capsule may occur predominantly from the solution to the interior of the capsules, 
leading to their burst (Figure 4-5). 
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Figure 4-5. Optical microscopy images of the capsules after the short-term stability study carried out at 
different time periods. A) 30/70 solid capsules, B) 30/70 liquefied capsules, C) 50/50 solid capsules, D) 
50/50 liquefied capsules. Photographs were taken with a stereomicroscope. 
 
Previous studies [28, 34, 36] have reported that solid capsules (non-liquefied) were 
mechanically more resistant than liquefied capsules. That can be attributed to the 
swelling effect induced by the citrate solution during production of the liquefied 
capsules. Nevertheless, in this work, statistically significant differences were not found 
in the stability of solid and liquefied alginate/i-carrageenan capsules, probably as a 
result of the structure and distribution of the mixed polymers used in this study, during 
capsule formation. According to these results, the capsules 30/70 SA-IC (solid and 
liquefied) were selected for the posterior cell encapsulation assays. 
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4.3.3 IN VITRO CYTOTOXICITY ASSESSMENT 
The metabolic activity and viability of the fibroblast cultured with leachables 
extracted from 30/70 and 50/50 SA-IC solid capsules were assessed using MTT test for 
three different periods of culture (24, 48 and 72 hours). Optical observations (before 
adding the MTT solution) revealed a good cell growth and attachment. Moreover, no 
changes in cell morphology were detected in comparison with negative control (Figure 
4-6), which demonstrated the non cytotoxicity of these capsules formulations. Indeed, 
the morphological characteristics of fibroblasts were maintained during the three days 
of extract/cell culture and no cell lyse was observed.  
 
 
Figure 4-6. Morphology of fibroblasts exposed to: a) 30/70 SA-IC capsules extracts; b) 50/50 SA-IC 
capsules extracts; c) latex extracts (positive control) and d) culture medium (negative control) incubated 
72 h at 37 ⁰C. Photographs were taken with an inverted optical microscope (20X). 
 
Nevertheless, the percentage of cell viability determined using MTT test in cells 
exposed to extracts of 50/50 SA-IC capsules was lower as compared to the cells 
exposed to the extract obtained from the 30/70 SA-IC capsules (Figure 4-7). These 
results might be explained based on the fact that the capsules with higher content of 
alginate (50/50) than 30/70 capsules could produce leachables, which induced some 
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reaction from the cells exposed to their extracts. Notwithstanding, in each capsules 
type the percentage of cell viability was very similar for all the culturing periods 
studied. 
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Figure 4-7. Metabolic activity of the L929 fibroblasts cultured with extracts obtained from 30/70 and 
50/50 SA-IC solid capsules for 24, 48 and 72 hours, determined using the MTT test. 
 
4.3.4 ENCAPSULATED CELL VIABILITY AND PROLIFERATION  
4.3.4.1 Optical microscopy analysis 
According to results obtained, mainly those regarding the mechanical stability 
evaluation, it was decided to use the 30/70 SA-IC solid and liquefied capsules, obtained 
using a chitosan solution of pH 5.0, for the cell encapsulation experiments. The results 
showed that in both types of capsules, the encapsulated cells maintained the viability. 
The optical microscopy images show the capsules in culture medium and stained with 
blue methylene, where the blue colour on the nucleus of the cells indicates the 
presence of living cells (Figure 4-8). Additionally, 7 days post-encapsulation, the cells 
exhibited similar shape and distribution in solid and liquefied capsules and no cell 
aggregates were observed. This is a relevant observation since previous studies 
showed that the cell aggregates could produce necrotic spaces within the capsules as a 
consequence of poor mass transfer [36, 53]. 
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Figure 4-8. Optical microscopy pictures showing encapsulated fibroblasts (density 5x103 cells per ml) 
within sodium alginate/iota-carrageenan (30/70) solid capsules pH 5.0. A1, A2 and A3) cells within solid 
capsules in culture medium (5X and 10X respectively); B1) cells within solid capsules in culture medium 
(20X); B2 and B3) Cells within solid capsules stained with blue methylene (20X and 40X respectively), 
after 72 h. 
 
Previous studies [26, 36] have demonstrated that cells enclosed in liquefied beads 
present an improved growth profile in comparison to the cells entrapped in solid 
capsules. However, in the system studied in this work, the solid and liquefied capsules 
formed using sodium alginate/iota-carrageenan as polyanions showed a similar 
behaviour. These results can be explained by the mixture and proportion of polymers 
used, as iota-carrageenan is present in higher proportion (70%) than sodium alginate 
(30%). In fact, iota-carrageenan confers an elastic structure to the core of the capsule, 
providing it with higher flexibility, in opposition to sodium alginate that confers a rigid 
structure [64, 65]. 
 
4.3.4.2 MTS test 
Cellular viability and proliferation were also determined using the MTS test after 
72 hours of culture, where fibroblasts cells encapsulated into capsules 30/70 SA-IC 
(solid and liquefied) were exposed to MTS solution. The solution used to form these 
capsules (sodium alginate/iota-carrageenan mixture 30/70) mixture with cells, was 
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also evaluated in this test as a control. The results suggested that the cell viability 
decreased in encapsulated cells but increased in the cell/solution mixture (Figure 4-9). 
However, the cell viability of both types of capsules did not show significant 
differences after 72 h of incubation, indicating that the citrate treatment may not be 
relevant to improve the capsules permeability an hence for cell viability, using this 
polymeric formulation.  
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Figure 4-9. Cell viability and proliferation of fibroblast entrapped within SA (sodium alginate)/IC (iota- 
carrageenan) capsules and in the polymeric solution SA/IC (ratio: 30/70), determined using the MTS 
test. 
 
On the other hand, with the culturing period, cell/solution showed increased cell 
viability with a homogeneous growth further demonstrating the non cytotoxicity of 
this mixture, confirming the results obtained in MTT assays. These results also indicate 
that the decrease in cell viability over time in the capsules may be due to the decrease 
in permeability resulting from the membrane formation during the capsule 
preparation. In fact, the cell growth is better in cells/solution SA-IC than in the capsules 
because the molecules and gases did not have to cross the membrane present in the 
capsule to reach the cells. 
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4.3.4.3 Fluorescents staining 
It is known that the Calcein-AM only stains viable cells and DAPI interacts with the 
double DNA in viable and fixed cells [58, 59]. In this study, the results obtained using 
fluorescent staining confirmed the cellular viability in fibroblasts cells encapsulated 
into capsules 30/70 (solid and liquefied), where it was evident the green and blue 
colour after 7 days of cell culture demonstrating the living cells (Figure 4-10). These 
dyes are indicative of cell membrane integrity and permeability. Additionally, these 
results confirm the permeability and non toxicity of the capsule developed with 
sodium alginate and iota-carrageenan polymers. Once again, it was not possible to 
determine differences in cell viability between encapsulated fibroblast into solid and 
liquefied capsules. The cells exhibited similar distribution and same fluorescence 
pattern in both type of capsules. However, after 7 days, the cells in both capsules 
showed low fluorescence, possibly because the decreased cell viability.  
In general, the results obtained are indicative that Calcein-AM and DAPI were able 
to penetrate alginate-carrageenan capsules contain living fibroblast in suspension with 
intact membrane, revealing, thus, cell viability in this structure. All capsules developed 
did not show differences in the cell viability and proliferation, confirming the results 
obtained in the MTS test. Moreover, the observations using fluorescents staining also 
did not demonstrate formation of cell aggregates. 
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Figure 4-10. Images obtained in the fluorescent microscope of encapsulated fibroblasts stained with 
Calcein-AM and DAPI dyes after: (A1-A3) 24 h, (B1-B3) 48 h, (C1-C3) 72 h and (D1-D3) 7 days. 
 
4.4 CONCLUSIONS  
All the developed capsules based on iota and kappa-carrageenan as well as these 
made from mixture of iota-carrageenan with alginate, exhibited spherical shape, 
smooth surface and revealed good stability in PBS and in culture medium. 
Iota-carrageenan capsules showed suitable properties for cell encapsulation and was 
selected to developed alginate/carrageenan capsules. 
Microcapsules developed via ionotropic gelation method based in the mixture of 
sodium alginate and iota-carrageenan solutions showed to be suitable for the 
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development of stable capsules, using chitosan as the main component of the 
capsule’s membrane. The mechanical properties of these capsules were mainly 
influenced by the alginate/carrageenan ratio used. 
The results of short-term stability evaluation suggested that capsules with high content 
of iota-carrageenan are more stable and their stability is not negatively affected by the 
citrate treatment.  
Cell encapsulation experiments showed that in both types of 30/70 SA-IC capsules 
(solid and liquefied) the cells maintained their viability and did not form cell 
aggregates. Moreover, these experiments demonstrated that the citrate treatment is 
not necessary to improve the permeability of iota-carrageenan/sodium alginate 
capsules with a high content of carrageenan (70%). 
The results obtained suggest that this new polymeric system based on mixtures of 
alginate with iota-carrageenan produce adequate and promissing systems for cell 
encapsulation that may found several applications in tissue engineering on other cell 
therapies. 
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CHAPTER 5 
 
5 PRELIMINARY STUDIES OF CELL ADHESION AND 
PROLIFERATION OF OSTEOBLASTIC-LIKE CELLS ON CHITOSAN 
POROUS HYBRIDS SCAFFOLDS 
 
5.1 INTRODUCTION 
 
Three dimensional porous structures have been recognized as the most Three 
dimensional porous structures have been recognized as the most appropriate scaffold 
design to sustain cell adhesion and proliferation [1, 2]. The material composition as 
well as structural characteristics such as external and internal architecture are crucial 
for the successful outcome of all scaffolds-based bone tissue-engineering strategies [3-
5]. These materials must comply with a large number of requirements such as 
biocompatibility, biodegradability, apart from adequate porosity and permeability [6, 
7] in order to allow the ingress of cells and nutrients, and the appropriate surface 
chemistry for enhanced cell attachment and proliferation [8]. 
Surface characteristics such as topography, chemistry or surface energy, play an 
essential role in cell adhesion onto biomaterials. As a result, cell attachment, adhesion 
and spreading belong to the first phase of cell/material interactions and the quality of 
this first phase will influence the capacity of cells to grow and differentiate when 
contacting with the tissue to regenerate [9]. 
A number of fabrication technologies have been applied to process biodegradable 
and bioresorbable materials into 3D-polymeric scaffolds of high porosity and surface 
area. The conventional techniques for scaffold fabrication include fibre bonding [10, 
11], solvent casting [11-15], particulate leaching [16], gas foaming [17-19], phase 
separation/emulsification [20-23], membrane lamination and melt molding [7, 24].  
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Additionally, others methods include extrusion, in situ polymerization [8, 25], 3D-
printing and selective laser sintering [6, 26, 27]. These last engineering technologies 
are highly controllable, reproducible and facilitate the manufacture of well-defined 3D-
structures [28]. 
In the case of bone applications, several scaffolds materials have been investigated 
including hydroxyapatite (HA) [29, 30], and natural polymers such as collagen [2, 31], 
fibrin [32], chitosan [33-40] chitin [7, 37] and starch based polymers [41-46], exhibited 
good biocompatibility and some cases osteoconductive properties.  
The aim of this work was to assess the cell response to several chitosan based 
scaffolds formulations.  
Previous studies showed that chitosan scaffolds are osteoconductive and can 
enhance bone formation both in vitro and in vivo [34, 36, 38, 47]. In spite, of its general 
acceptance as tissue biocompatible material, chitosan is mechanically weak and 
unstable and unable to maintain a predefined shape for transplantation as a result of 
swelling [36]. 
In our group, chitosan based scaffolds (porous structures) have been produced by 
freeze-drying [25, 30, 33] . The scafolds’s properties, such as porosity can be 
controlled by the treatments applied to the scaffolds, such as crosslinking, 
neutralization with alkali solutions and control of the pH of the initial polymeric 
solution. It is possible to control the porosity in the 20-1000 µm range [48]. 
Methodologies as sol-gel process focus on the modification of the chitosan 
structure by introducing chemical cross-linkages between the reactive groups of 
polymer and the siliceous skeleton. Then, a more effective bonding between the 
organic and the inorganic phases can be achieved, improving the mechanical 
performance, chemical stability and controlled water absorption [33]. 
In this work, it was assessed the cell response to several chitosan based scaffolds 
formulations that are being studied for applications as supports for bone tissue 
regeneration. The biological response of the scaffolds was evaluated by seeding and 
culturing the matrices for different periods of time with osteoblastic cells; the 
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morphology of the cells seeded and cultured onto the scaffolds was examined by SEM 
(scanning electron microscope) and the cell viability and metabolic activity was 
evaluated using DNA and ALP assays.  
 
5.2 MATERIALS AND METHODS 
5.2.1 TEST MATERIALS 
In this work, chitosan based porous structures were produced by means of combining 
a sol-gel process and the freeze-drying technique, as described previously [25, 33]. 
Briefly, chitosan (powder form) was dissolved in 0.2 M acetic acid solution at 
concentration of 4 wt% to obtain a homogeneous solution. Appropriate amounts of 
tetraethoxysilane (TEOS) and 0.5 M chloridric acid (HCl) solution were added to the 
chitosan solution under constant stirring for 24 and 72 hours. The method involves the 
hydrolysis and condensation of inorganic component (TEOS) in the chitosan matrix 
forming hydrogen bonding between the organic and inorganic phase. Then, the 
mixture was poured into Petri dish and allowed to dry at room temperature for several 
days. By its turn, the porous hybrids were obtained by transferring the mixture into a 
mould, freezing at -80 ⁰C overnight, folowed by freze-drying for the period of 4 days 
to completely remove the solvent. The neutralization of porous hybrids was performed 
by soaking in a 0.1 M sodium hydroxide solution for 10 min and washing abundantly 
with distilled water until reaching the pH 7.0. Afterward, the porous structures are 
placed again in the freezing at -80 ⁰C overnight, folowed by freze-drying for the 
period of 2 days. The scaffolds conditions tested and the correspondent sample 
designation is presented in theTable 5-1. All the samples/scaffolds obtained, 
corresponding to different formulations, were cut into cylinders of 0.6 cm (b) x 0.3 cm 
(h) x 0.25 cm (r) and sterilized by ethylene oxide prior to all the biological studies 
performed. 
  
Chapter 5. Preliminary studies of cell adhesion and 
proliferation of osteoblastic-like cells on chitosan 
porous scaffolds 
Novel polymeric systems based on natural materials: 
development and biological performance 
 
131 
Table 5-1. Conditions of the several chitosan porous hybrid scaffolds 
Sample polymer (g) 
TEOS:HCl 
(wt%) 
CaCl2 (g) 
Reaction time 
(hours) 
CT5 79.2 0.1:0.1 - 72 
CT6 79.2 0.1:0.1 0.0788 72 
CT7 79.2 0.1:0.01 - 72 
CT8 40 0.1:0.1 - 24 
 
5.2.2 CELL CULTURE STUDIES 
A cell line of osteoblastic like cells-SaOS (human osteosarcoma) was selected for 
the culture studies as the developed 3D-chitosan scaffolds are aimed to be used in 
bone tissue regeneration applications.  
The cell line (SaOS) was obtained from European Collection of Cell Cultures (ECC, 
UK) and was cultured in 75 cm2 culture flasks, using Dulbeco’s Modifed Eagle’s 
Medium-low glucose (DMEM-Sigma-Aldrich, Portugal), supplemented with 10 % foetal 
bovine serum (FBS, Biochrom AG, Germany), 1% antibiotic/antimycotic (Invitrogen, 
Portugal) and sodium bicarbonate (Sigma, Portugal) at 37 ⁰C in a 5 % CO2 incubator 
[41]. The culture medium was changed every 2 days and cells were grown until 
confluence, before starting the in vitro assays. Chitosan based scaffolds were seeded 
with cells and cultured for different periods of time. The cells adhesion and 
proliferation onto chitosan scaffolds developed using different formulations was 
assessed by scanning electron microscopy (SEM) and using the DNA and ALP assays as 
described bellow. 
 
5.2.3 SEEDING AND CULTURING OSTEOBLASTIC-LIKE CELLS INTO 3D-CHITOSAN 
SCAFFOLDS 
Osteoblasts cells were harvested before reaching confluence from 75 cm2 culture 
flasks using trypsin-EDTA (Invitrogen, Portugal), re-suspended in 5 ml DMEM culture 
medium and centrifuged. Cell suspension was prepared in order to seed 5 x 105 cells 
per sample. The scaffolds were placed in 48 well non-adherents culture plates. For 
each different scaffold material was placed 6 samples and 300 µl of cell suspension 
was seeded onto the surface of each scaffold. The culture plate was transferred in a 
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5% CO2 incubator for 3 hours at 37 ⁰C. After this time, 1 ml of DMEM culture medium 
was added into each well-culture plate and the samples cultured for different periods 
of time (3, 7 and 14 days). The culture medium was changed every two days. At the 
end of each culturing period-scaffolds were washed with PBS and transferred to 15 ml 
tubes containing 1 ml of ultra-pure water and frozen at -80 ⁰C before using for DNA 
and ALP analysis. The remaining scaffolds were further treated for SEM observations. 
 
5.2.4 DNA QUANTIFICATION IN LYSED CELLS 
The DNA content of each scaffold was measured using a Picogreen® dsDNA 
Quantitation Kit (Invitrogen/Molecular Probes) [49]. PicoGreen® dsDNA quantitation 
reagent is an ultrasensitive fluorescent nucleic acid stain for quantify double-stranded 
DNA (dsDNA) in solution [50].  
For the DNA quantification, the samples were defrosted using ultrasound bath for 
about 15 minutes. Afterwards, 28.7 µl of sample or standard + 71.3 µl of PicoGreen 
solution and 100 µl 1X TE (n = 4) were mixture using 96 culture plates (white opaque). 
The standard solutions were prepared in ultra pure water from 0.0 to 2.0 v/v. Then, 
the culture plates were incubated in the dark for 10 minutes. The fluorescence was 
read in the microplate reader (BIO-TEK – Synergy HT) at 485/20 nm for excitation and 
528/20 nm for emission. DNA concentration was read from standard graph. The DNA 
quantification of each sample was calculated by correlation with the DNA of a known 
amount osteoblasts (SaOS) [49].  
 
5.2.5 ALKALINE PHOSPHATASE (ALP) ASSAY 
ALP is an enzyme secreted from osteoblasts. It is thought to promote crystal 
formation in matrix vesicles by removing nucleation inhibitors. It is inhibited by 
glucocorticoids and parathyroid hormone (PTH) [51].  
In this work, the ALP activity was measured using a Sigma Diagnostic kit [49], 
where alkaline phosphatase activity from the scaffolds-cells samples was quantified by 
the specific conversion of p-nitrophenyl phosphate (pNPP) to p-nitrophenol (pNP). For 
the ALP quantification, the samples were prepared as describe for DNA assays, where 
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the samples were defrosted using ultrasound bath for about 15 minutes. Following 
from each tube/scaffold it was taken 20 µl of sample solution and added to a 96 well 
culture plate (n = 4). Then, 60 µl of substrate solution ALP (p-nitrophenyl phosphate -
pNPP) was mixed. The 96-well plate was incubated at 37 ⁰C for 45 minutes in the dark. 
After this period the reaction was stopped using 80 µl of stop solution and then the 
standard solutions were placed in the same 96-well plate (the standard solutions were 
prepared according to Table 5-2Error! Reference source not found.). The absorbance 
was determined at 405 nm using the microplate reader (BIO-TEK – Synergy HT) [42, 
49]. Product concentration was read from standard graph. The results were expressed 
in pNP produced by sample/day of cell culture. 
 
Table 5-2. Preparation of standard solutions - ALP assays 
pNP Stock solution Stop solution [µl] 
Standard concentrations 
[µmol/ml] 
0.0 160.0 0 
0.8 159.2 5 
1.6 158.4 10 
2.4 157.6 15 
3.2 156.8 20 
 
5.2.6 SEM ANALYSIS OF THE CELL SEEDED SCAFFOLDS 
At the end of each culturing period, the chitosan scaffolds-cells samples were 
rinsed twice with phosphate buffered saline solution (PBS, Sigma-Portugal) and 
subsequently dehydrated using an increased concentration series of ethanol solutions 
(25%, 30%, 50%, 70%, 80%, 90% and 100% - each 30 min). The samples were then 
dried at room temperature, and sputter coated with gold before observation in a 
scanning electron microscope (SEM, Leica Cambridge S360). 
 
5.3 RESULTS AND DISCUSSION 
5.3.1 CELLULAR ADHESION AND PROLIFERATION-SEM ANALYSIS 
Chitosan based scaffolds were cell seeded with a SaOS cell line in order to evaluate 
the cell/material interaction with respect to cell adhesion and proliferation. The SEM 
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analysis performed after 3, 7 and 14 days of cell culture, revealed that the cell 
attachment and proliferation of the osteoblasts cells in contact with all scaffolds 
formulations surface was low. Only for the CT6 formulation a good response during all 
the culture time could be observed. 
According to SEM micrographs (Figure 5-1), the best scaffold formulation was the 
CT6 as it was possible to observe cell growth, attachment and spread on its surface 
after only 3 days of culture. It is possible to detect cells colonizing the surface and 
inner regions (porous) of the scaffold. The rest of the formulations showed a very 
different behaviour, i.e., the samples exhibited lower cell adherence with cell cluster 
formation. 
 
 
Figure 5-1. SEM micrographs showing SaOS osteoblasts cultured on chitosan scaffold after 3, 7 and 14 
days of cell culture. A1 to A3) CT5 scaffold, B1 to B6) CT6 scaffold, C1 to C3) CT7 scaffold. 
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The different behaviour of the different formulations of chitosan scaffolds (non 
homogeneous cell distribution and lower cell attachment) can be explained by the 
monopolar basic nature of chitosan, which does not interact well with the bipolar 
extracellular matrix proteins present in the bovine serum proteins of the culture 
medium [52]. 
In the case of CT6 formulation, the higher cell growth could be explained by the 
content of CaCl2 in the mixture with the polymer. Indeed, the osteoblasts cells have 
affinity with calcium for the formation, secretion and mineralization of extracellular 
bone [9, 51]. Additionally, the quantity of polymer (79.2 g) and reaction time (72 h) can 
affect cell proliferation. Also, the addition of calcium chloride provides Ca2+ ions that 
associated to presence of silanol groups (Si-OH) in these materials can induce the 
biomineralization [53]. 
Previous chitosan scaffolds studies suggested good cell proliferation and 
differentiation in porous structures based chitosan [29, 30, 35]. However, in 
such studies it was developed 3D-scaffolds using different chitosan 
combination such as chitosan/hydroxyapatite [30], chitosan/gelatin [29] and 
chitosan/chondroitin sulphate [54] using different techniques such as sintering 
and a freeze-drying technique [30], solid-liquid phase separation and 
subsequent sublimation [29] and interpolyelectrolyte complex/lyophilization 
method [54]. 
In this particular study, the low cell adhesion of osteoblasts generally observed in 
the SEM analysis on chitosan porous scaffolds suggests the need for further 
improvements regarding the scaffolds formulations, in order to promote a better cell 
adhesion in these materials, as well in the seeding protocol. 
 
5.3.2 DNA ANALYSIS 
Figure 5-2, shows the results obtained by DNA assay after different periods of 
culturing into chitosan based scaffolds correspondent to different formulations. The 
results demonstrated a low cell density after 3 days culturing. 
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Figure 5-2. Number of cells on chitosan based scaffolds with different formulations after 3, 7 and 14 
days of cell culture obtained in the DNA Quantification assay. 
 
However, DNA values showed a significant and consistent enhancement after 7 
and 14 days of culture for all formulations comparatively to 3 days culturing (Figure 
5-2). In fact, the results obtained from the DNA assay showed the occurrence of cell 
growth and attachment in all the porous chitosan constructs. DNA results are not in 
agreement with the SEM observations which may be explained by the detachment of 
cells during the procedure for preparing samples for SEM observations. 
Nevertheless, the number of cells present in the scaffolds after 7 and 14 days of 
culture are still low if compared to the amount of cells initially seeded which may be 
explained by a low cell-seeding efficiency due to the procedure used and/or to the 
nature of the surface of the chitosan scaffolds, that may not promote significant initial 
cell attachment, as it was demonstrated in previous chapter for chitosan based 
membranes without any surface treatment. 
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5.3.3 ALP ANALYSIS 
The functional activity of the osteoblasts on the chitosan scaffolds was determined 
by quantifying the ALP activity. Figure 5-3, shows the ALP activity obtained after 
different culture periods of the chitosan based scaffolds with different formulations. 
This assay demonstrated the relations of enzymatic activity of osteoblasts cells with 
cells number reported in DNA quantification assay. It is clear that several formulations 
exhibited a constant and increasing enzymatic activity with increasing culture. 
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Figure 5-3. ALP activity of osteoblasts cells after 3, 7 and 14 days of cell culture on chitosan based 
scaffolds. 
 
The increase of ALP activity with culture time demonstrates a consistent growth of 
cells and cell metabolic activity in the porous chitosan structure as reported in 
previous studies [29], where the existence of a ceramic phase, plays an important role. 
The data in Figure 5-3 is fully consistent with the DNA analysis results (Figure 5-2) 
strengthening the hypothesis that some of the formulations that were tested are able 
to support cell development within their structures. 
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5.4 CONCLUSIONS 
 
The biological response of chitosan scaffolds cross-linked with TEOS, through a sol-
gel process, was accessed. Except one of the formulations all the other formulations 
demonstrated low initial cell attachment and proliferation. 
However, after 3 days of culture the cells start to proliferate and grow over the 
studied culture time (14 days). This suggests that, as demonstrated for chitosan 
membranes, the chitosan scaffolds may need to be submitted to a surface treatment 
(such as plasma treatment) to enhance cell attachment on the surface of these 
scaffolds. Additionally, it may also be required the optimization of the scaffolds 
formulations used, as clearly one of the formulations used resulted better than the 
remaining ones, in terms of initial cell attachment and growth. 
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CHAPTER 6  
 
6 GENERAL CONCLUSIONS 
 
The present work had two major goals, the first was to study the biological 
response of chitosan based membranes and porous 3D-scaffolds, that are being 
studied for applications as supports for growing tissue substitutes, in special for the 
regeneration of skin and bone tissue, while the second aimed at the development of 
new systems for cell encapsulation based on two natural polymers, alginate and 
carrageenan, that can be used in different tissue regeneration or other cell based 
therapies. 
The main conclusions of this thesis are presented according to the above 
mentioned objectives. 
 
BIOCOMPATIBILITY OF CHITOSAN BASED MEMBRANES AND SCAFFOLDS AND 
MODIFICATION OF CELL ADHESION BY PLASMA SURFACE TREATMENTS 
The MEM extraction and MTT test showed that the leachables released by all 
membranes formulations studied were not harmful to the cells. Additionally, in both 
assays, changes in cell morphology and cell metabolism were not evidenced. 
The surface of the chitosan membranes modified by plasma treatment, using 
argon and nitrogen gas showed, in all the in vitro assays performed, enhanced cell 
attachment and proliferation, as compared to untreated membranes. 
SEM observations of the cells seeded onto chitosan membranes showed that cell 
proliferation rates were similar in all treated surfaces using both plasma treatments, 
under different conditions. However, MTS showed some differences in cell 
proliferation, depending on the gas plasma type, demonstrating that nitrogen plasma 
produced better results as compared to argon plasma. The enhancement in cell 
proliferation observed in the membranes surface treated by plasma may be explained 
by the raise in the levels of oxygen and nitrogen obtained in the chitosan membranes 
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surface after these treatments. As a result, chitosan membranes treated by plasma 
surface modification demonstrated to be adequate for the cell adhesion and growth, 
demonstrating the high potential of chitosan membranes treated by plasma for future 
applications in the biomedical field, namely in skin regeneration. 
Several formulations of chitosan based scaffolds were developed using 
methodologies that combine sol-gel process and freeze-drying techniques. In general, 
all formulations demonstrated low initial cell attachment and proliferation, except one 
of the formulations. This suggests that, as demonstrated for chitosan membranes, the 
chitosan scaffolds may need to be submitted to a surface treatment (such as plasma 
treatment) to enhance cell attachment on the surface of these scaffolds. Additionally, 
it may also be required the optimization of the scaffolds formulations used, as clearly 
one of the formulations used resulted better than the remaining ones, in terms of 
initial cell attachment and growth. 
 
DEVELOPMENT OF NEW CELL ENCAPSULATION SYSTEMS BASED ON ALGINATE AND 
CARRAGEENAN 
Microcapsules were developed using iota and kappa carrageenan as well as 
mixtures of iota-caragenan with alginate. Chitosan was used to form the capsule’s 
membranes. All capsules developed exhibited spherical shape, smooth surface and 
revealed good stability in PBS and in culture medium. 
Iota-carrageenan constitutes soft and elastic gels, forming capsules with more 
permeability than kappa-carrageenan capsules, showing to be suitable for cell 
encapsulation.  
The microcapsules based on mixture of sodium alginate and iota-carrageenan 
solutions showed that the mechanical properties of these capsules were mainly 
influenced by the alginate/carrageenan ratio used. The results of short-term stability 
evaluation suggested that capsules with high content of iota-carrageenan are more 
stable and their stability is not negatively affected by the citrate treatment. 
Cell encapsulation experiments showed that these capsules maintained cell viability 
and did not form cell aggregates. 
The results obtained suggest that this new polymeric system based on mixtures of 
alginate with iota-carrageenan produce adequate alternative systems for cell 
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encapsulation that may found several applications in tissue engineering or other cell 
based therapies. Nevertheless, these systems require future studies in order to 
demonstrate all their potential in biomdical applications. 
 
